<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="other">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">CdhY8QYY7zcKNb9G9BFHpCc</article-id>
      <article-id pub-id-type="other">00025</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001100025</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500125</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010001100025</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Atualiza&#231;&#227;o Cl&#237;nica</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Indicadores antropom&#233;tricos de resist&#234;ncia &#224; insulina</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vasques</surname>
            <given-names>Ana Carolina</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosado</surname>
            <given-names>Lina</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosado</surname>
            <given-names>Gilberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Rita de Cassia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Franceschini</surname>
            <given-names>Sylvia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Geloneze</surname>
            <given-names>Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Campinas</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual de Campinas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Vi&#231;osa</named-content>
          <named-content content-type="state">Minas Gerais</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Vi&#231;osa</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>1</issue>
      <fpage>e14</fpage>
      <lpage>e23</lpage>
      <history>
        <date date-type="accepted">
          <day>11</day>
          <month>05</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>03</month>
          <year>2009</year>
        </date>
        <date date-type="received">
          <day>29</day>
          <month>08</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Alguns estudos t&#234;m analisado a efici&#234;ncia de indicadores antropom&#233;tricos em predizer resist&#234;ncia &#224; insulina (RI), por serem mais econ&#244;micos e acess&#237;veis. Neste estudo, objetivou-se discutir sobre as medidas e &#237;ndices antropom&#233;tricos que t&#234;m sido associados &#224; RI. Realizou-se um levantamento bibliogr&#225;fico nas bases Scielo, Science Direct e Pubmed. Dentre os estudos analisados, per&#237;metro da cintura e di&#226;metro abdominal sagital apresentaram melhor capacidade preditiva para RI, com resultados mais consistentes. As rela&#231;&#245;es cintura/coxa, cintura/estatura, pesco&#231;o/coxa, o &#237;ndice de conicidade e o &#237;ndice sagital demonstraram resultados positivos, contudo mais estudos s&#227;o necess&#225;rios para consolid&#225;-los como preditores de RI. Os resultados obtidos com o uso do &#237;ndice de massa corporal e da rela&#231;&#227;o cintura/quadril foram mais inconsistentes. Sugere-se a realiza&#231;&#227;o de estudos avaliando o desempenho desses indicadores em predizer RI na popula&#231;&#227;o brasileira, pois resultados de estudos feitos com outras popula&#231;&#245;es muitas vezes n&#227;o s&#227;o aplic&#225;veis &#224; nossa, devido &#224;s diferen&#231;as &#233;tnicas resultantes da grande miscigena&#231;&#227;o no Pa&#237;s.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Resist&#234;ncia &#224; insulina</kwd>
        <kwd>antropometria</kwd>
        <kwd>obesidade</kwd>
        <kwd>gordura intra-abdominal</kwd>
        <kwd>circunfer&#234;ncia abdominal</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>29</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ATUALIZA&#199;&#195;O CL&#205;NICA</bold>
    </p>
    <p>Indicadores antropom&#233;tricos de resist&#234;ncia &#224; insulina</p>
    <p>
      <bold>Ana Carolina Vasques<sup>I</sup>; Lina Rosado<sup>I</sup>; Gilberto Rosado<sup>I</sup>; Rita de Cassia Ribeiro<sup>I</sup>; Sylvia Franceschini<sup>I</sup>; Bruno Geloneze<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Universidade Federal de Vi&#231;osa (UFV), Vi&#231;osa, MG </p>
    <p><sup>II</sup>Universidade Estadual de Campinas (UNICAMP), Campinas, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p>Alguns estudos t&#234;m analisado a efici&#234;ncia de indicadores antropom&#233;tricos em predizer resist&#234;ncia &#224; insulina (RI), por serem mais econ&#244;micos e acess&#237;veis. Neste estudo, objetivou-se discutir sobre as medidas e &#237;ndices antropom&#233;tricos que t&#234;m sido associados &#224; RI. Realizou-se um levantamento bibliogr&#225;fico nas bases <italic>Scielo</italic>, <italic>Science Direct</italic> e <italic>Pubmed</italic>. Dentre os estudos analisados, per&#237;metro da cintura e di&#226;metro abdominal sagital apresentaram melhor capacidade preditiva para RI, com resultados mais consistentes. As rela&#231;&#245;es cintura/coxa, cintura/estatura, pesco&#231;o/coxa, o &#237;ndice de conicidade e o &#237;ndice sagital demonstraram resultados positivos, contudo mais estudos s&#227;o necess&#225;rios para consolid&#225;-los como preditores de RI. Os resultados obtidos com o uso do &#237;ndice de massa corporal e da rela&#231;&#227;o cintura/quadril foram mais inconsistentes. Sugere-se a realiza&#231;&#227;o de estudos avaliando o desempenho desses indicadores em predizer RI na popula&#231;&#227;o brasileira, pois resultados de estudos feitos com outras popula&#231;&#245;es muitas vezes n&#227;o s&#227;o aplic&#225;veis &#224; nossa, devido &#224;s diferen&#231;as &#233;tnicas resultantes da grande miscigena&#231;&#227;o no Pa&#237;s. </p>
    <p><bold>Palavras-chave:</bold> Resist&#234;ncia &#224; insulina, antropometria, obesidade, gordura intra-abdominal, circunfer&#234;ncia abdominal.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A s&#237;ndrome de resist&#234;ncia &#224; insulina (RI) &#233; um dos principais fatores de risco para as doen&#231;as cardiovasculares, apresentando elevada morbimortalidade e elevados custos socioecon&#244;micos. A RI, considerada o elo entre as demais altera&#231;&#245;es fisiol&#243;gicas que comp&#245;em o complexo quadro dessa s&#237;ndrome, est&#225; associada &#224; obesidade visceral, &#224; hipertens&#227;o arterial, &#224; intoler&#226;ncia &#224; glicose, ao diabete tipo 2, &#224;s dislipidemias, &#224; hiperuricemia, entre outras altera&#231;&#245;es metab&#243;licas<sup>1-3</sup>. </p>
    <p>A avalia&#231;&#227;o da RI tem recebido consider&#225;vel aten&#231;&#227;o nos &#250;ltimos anos. No Brasil, a determina&#231;&#227;o da RI ainda n&#227;o faz parte dos exames m&#233;dicos de rotina e n&#227;o est&#225; dispon&#237;vel na maioria dos servi&#231;os de sa&#250;de. Os m&#233;todos laboratoriais para a determina&#231;&#227;o da RI s&#227;o dispendiosos e com defici&#234;ncias de padroniza&#231;&#227;o para a sua execu&#231;&#227;o, limitando a compara&#231;&#227;o entre os resultados de diferentes laborat&#243;rios e a sua aplica&#231;&#227;o na pr&#225;tica cl&#237;nica<sup>4</sup>.</p>
    <p>Estudos t&#234;m correlacionado as medidas antropom&#233;tricas isoladas e os &#237;ndices antropom&#233;tricos com a RI<sup>5-9</sup>. Os indicadores antropom&#233;tricos surgem como uma alternativa para a avalia&#231;&#227;o da RI com menor custo e maior facilidade de aplica&#231;&#227;o nos estudos epidemiol&#243;gicos e nos servi&#231;os de aten&#231;&#227;o b&#225;sica &#224; sa&#250;de. Em virtude da import&#226;ncia desse tema, objetivou-se discutir sobre as principais medidas e &#237;ndices antropom&#233;tricos que t&#234;m sido associados &#224; RI.</p>
    <p>
      <bold>Metodologia</bold>
    </p>
    <p>Realizou-se um levantamento bibliogr&#225;fico com consulta a peri&#243;dicos dispon&#237;veis nas bases cient&#237;ficas <italic>Scielo</italic>, <italic>Science Direct</italic> e <italic>Pubmed</italic>. Os descritores utilizados para a busca dos artigos foram: resist&#234;ncia &#224; insulina (<italic>insulin resistance</italic>); antropometria (<italic>anthropometry</italic>); &#237;ndice de massa corporal (<italic>body mass index</italic>); circunfer&#234;ncia da cintura (<italic>waist circumference</italic>); di&#226;metro abdominal sagital (<italic>sagittal abdominal diameter</italic>); rela&#231;&#227;o cintura-quadril (<italic>waist-hip ratio</italic>); &#237;ndice de conicidade (<italic>conicity index</italic>); rela&#231;&#227;o cintura-coxa (<italic>waist-thigh ratio</italic>); circunfer&#234;ncia do pesco&#231;o (<italic>neck circumference</italic>); e rela&#231;&#227;o cintura-estatura (<italic>waist-stature ratio</italic>). Foram selecionados artigos publicados entre 1990 e 2007, al&#233;m da incorpora&#231;&#227;o de trabalhos cl&#225;ssicos referentes ao tema publicados anteriormente. A maioria dos estudos inclu&#237;dos nesta revis&#227;o foi transversal. Tamb&#233;m foram discutidos alguns trabalhos do tipo caso-controle e algumas coortes. Foram inclu&#237;dos artigos caracterizados por rigor cient&#237;fico no tocante ao tamanho amostral e an&#225;lise estat&#237;stica adequados aos objetivos do estudo.</p>
    <p>
      <bold>Resist&#234;ncia &#224; insulina</bold>
    </p>
    <p>
      <bold>Determina&#231;&#227;o laboratorial</bold>
    </p>
    <p>A RI pode ser determinada de forma direta, a partir da administra&#231;&#227;o de quantidade predeterminada de insulina ex&#243;gena, ou de forma indireta, baseando-se nas concentra&#231;&#245;es de insulina end&#243;gena<sup>10</sup>. </p>
    <p>O <italic>clamp</italic> euglic&#234;mico hiperinsulin&#234;mico &#233; um exemplo de t&#233;cnica direta que permite a determina&#231;&#227;o da quantidade de insulina metabolizada pelos tecidos perif&#233;ricos durante a estimula&#231;&#227;o com insulina. Embora atualmente seja a t&#233;cnica padr&#227;o-ouro para avalia&#231;&#227;o da RI <italic>in vivo</italic>, &#233; dispendiosa, demorada e de alta complexidade, sendo invi&#225;vel sua aplica&#231;&#227;o em estudos populacionais, e principalmente na pr&#225;tica cl&#237;nica<sup>11</sup>. </p>
    <p>O &#237;ndice HOMA (<italic>Homeostasis Model Assessment</italic>) representa uma das alternativas &#224; t&#233;cnica de <italic>clamp </italic>para avalia&#231;&#227;o da RI. Ele &#233;<italic> um</italic> modelo matem&#225;tico que prediz o n&#237;vel de RI a partir da glicemia e insulinemia basais nas condi&#231;&#245;es de homeostase, sendo representado pela equa&#231;&#227;o<sup>12</sup>:</p>
    <p>HOMA = [Insulinemia de jejum (mU/l) x Glicemia de jejum (mmol/l)] / 22,5</p>
    <p>O HOMA vem sendo amplamente utilizado, principalmente em estudos populacionais, devido &#224; facilidade de sua aplica&#231;&#227;o e &#224; correla&#231;&#227;o forte e significante com as t&#233;cnicas diretas de avalia&#231;&#227;o da RI observadas nos trabalhos de valida&#231;&#227;o<sup>13,14</sup>. Contudo, para diagn&#243;stico ou acompanhamento individual, sua utiliza&#231;&#227;o ainda requer cautela nas quest&#245;es relacionadas &#224; amostragem sangu&#237;nea e &#224; deficiente padroniza&#231;&#227;o de ensaios a serem utilizados pelos laborat&#243;rios na dosagem de insulina<sup>4</sup>, apontando a necessidade de m&#233;todos mais acess&#237;veis e vi&#225;veis para a pr&#225;tica cl&#237;nica.</p>
    <p>
      <bold>Indicadores antropom&#233;tricos</bold>
    </p>
    <p>O desenvolvimento da tomografia computadorizada e da imagem de resson&#226;ncia magn&#233;tica representou um avan&#231;o importante na pesquisa de composi&#231;&#227;o corporal em seres humanos, pois permitem a mensura&#231;&#227;o acurada e precisa das gorduras visceral e subcut&#226;nea localizadas na regi&#227;o abdominal. A ultra-sonografia e a DEXA (<italic>dual energy x-ray absorptiometry</italic>) tamb&#233;m podem ser utilizadas na avalia&#231;&#227;o da gordura abdominal, embora essa &#250;ltima n&#227;o fa&#231;a a distin&#231;&#227;o entre gordura subcut&#226;nea e visceral<sup>15,16</sup>. Todavia, essas t&#233;cnicas s&#227;o dispendiosas e muitas vezes indispon&#237;veis.</p>
    <p>As medidas antropom&#233;tricas s&#227;o indicadores do estado nutricional, apresentam baixo custo, inocuidade, simplicidade em sua execu&#231;&#227;o e t&#234;m servido como indicadores da obesidade<sup>17</sup>. As correla&#231;&#245;es entre indicadores antropom&#233;tricos e RI t&#234;m sido vastamente estudadas, destacando-os como indicadores n&#227;o invasivos para a avalia&#231;&#227;o do risco de RI, tanto na pesquisa epidemiol&#243;gica como na pr&#225;tica cl&#237;nica. </p>
    <p>Os &#237;ndices antropom&#233;tricos podem ser classificados segundo o tipo de obesidade avaliada<sup>17</sup>. Entre os indicadores de obesidade central est&#227;o o per&#237;metro da cintura (PC), o di&#226;metro abdominal sagital (DAS), o &#237;ndice de conicidade (ICO) e a rela&#231;&#227;o cintura/estatura (RCE). A distribui&#231;&#227;o da gordura corporal tem sido avaliada pela rela&#231;&#227;o cintura/quadril (RCQ), pelo &#237;ndice sagital (IS), pela rela&#231;&#227;o cintura/coxa (RCCoxa) e pela rela&#231;&#227;o pesco&#231;o/coxa (RPCoxa). Para a obesidade generalizada, o &#237;ndice de massa corporal (IMC) tem sido o mais utilizado. A <xref ref-type="table" rid="a25tab01">Tabela 1</xref> sumariza os principais estudos discutidos nesta revis&#227;o que avaliaram os indicadores antropom&#233;tricos como preditores de RI.</p>
    <p content-type="asset">
      <table-wrap id="a25tab01">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gt01.jpg"/></table-wrap>
    </p>
    <p>Embora os indicadores de obesidade estejam relacionados &#224; RI, vale alertar que a RI n&#227;o &#233; uma altera&#231;&#227;o metab&#243;lica exclusiva de indiv&#237;duos portadores de obesidade e de diabete melito tipo 2, como acontece nos pacientes portadores de diabete lipoatr&#243;fico, em que h&#225; defeito gen&#233;tico da a&#231;&#227;o da insulina em indiv&#237;duos magros. Da mesma forma, alguns pacientes com IMC normal podem apresentar RI em virtude do ac&#250;mulo de gordura visceral, constituindo o fen&#243;tipo conhecido como MONW <italic>- Metabolically Obese Normal Weight</italic><sup>18</sup>. </p>
    <p>
      <bold>Per&#237;metro da cintura</bold>
    </p>
    <p>A praticidade de aplica&#231;&#227;o do per&#237;metro da cintura (PC), a sua associa&#231;&#227;o com fatores de risco cardiovascular e a correla&#231;&#227;o forte com a &#225;rea de gordura visceral medida por tomografia computadorizada, da ordem de 0,73 a 0,81<sup>19,20</sup>,s&#227;o caracter&#237;sticas que o tornaram o indicador de adiposidade abdominal mais utilizado. Al&#233;m do mais, a avalia&#231;&#227;o do PC est&#225; nas propostas do <italic>European Group for the Study of Insulin Resistance</italic><sup>21</sup>, da <italic>International Diabetes Federation</italic><sup>22</sup> e do<italic> National Cholesterol Education Program</italic> - NCEP-ATP III<sup>23 </sup>para o diagn&#243;stico da s&#237;ndrome de RI.</p>
    <p>Em 1995, Han e cols.<sup>24</sup> demonstraram que valores de PC acima de 80 e 88 cm para as mulheres e acima de 94 cm e de 102 cm para os homens indicavam risco aumentado e muito aumentado, respectivamente, de complica&#231;&#245;es metab&#243;licas. Posteriormente, o NCEP-ATP III<sup>23</sup> adotou os valores de 88 e 102 cm para o diagn&#243;stico de obesidade central em mulheres e homens, respectivamente, os quais t&#234;m sido utilizados inclusive no Brasil. As popula&#231;&#245;es diferem entre si de acordo com o n&#237;vel de risco apresentado para um dado PC, sendo imposs&#237;vel a determina&#231;&#227;o de pontos de corte globalmente aplic&#225;veis. A <italic>International Diabetes Federation</italic> recomenda a utiliza&#231;&#227;o de diferentes pontos de corte segundo a etnia (<xref ref-type="table" rid="tab2">Tabela 2</xref>)<sup>22</sup>.</p>
    <table-wrap id="tab2">
      <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gt02.jpg"/></table-wrap>
    <p>Embora o PC seja largamente difundido, h&#225; descri&#231;&#245;es diferentes para a aferi&#231;&#227;o e, consequentemente, aus&#234;ncia de consenso entre os pesquisadores e protocolos publicados, o que pode gerar conflitos no momento da tomada da medida. Entre as mais utilizadas est&#227;o o ponto m&#233;dio entre a crista il&#237;aca e a &#250;ltima costela, recomendado pela Organiza&#231;&#227;o Mundial da Sa&#250;de<sup>25</sup>; a menor cintura entre o t&#243;rax e o quadril, recomendada pelo <italic>Anthropometric Standardization Reference Manual</italic><sup>26</sup>; o n&#237;vel imediatamente acima das cristas il&#237;acas, recomendado pelo <italic>National Institute of Health</italic><sup>27</sup>; e o n&#237;vel umbilical<sup>8 </sup>(<xref ref-type="fig" rid="fig1">Figura 1</xref>).</p>
    <fig id="fig1">
      <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf01.jpg"/></fig>
    <p>Ross e cols. <sup>28</sup> verificaram que o protocolo utilizado para a mensura&#231;&#227;o do PC n&#227;o possui influ&#234;ncia substancial em sua associa&#231;&#227;o com as doen&#231;as cardiovasculares e o diabete tipo 2. J&#225; no estudo de Wang e cols. <sup>29</sup>, embora n&#227;o tenham sido realizadas correla&#231;&#245;es entre PC e risco de morbidades, os autores sugerem que as compara&#231;&#245;es entre diferentes trabalhos somente s&#227;o v&#225;lidas quando o mesmo local anat&#244;mico &#233; utilizado para a aferi&#231;&#227;o. Esses pesquisadores realizaram compara&#231;&#245;es entre as medidas de PC tomadas em quatro locais (menor cintura; imediatamente abaixo da &#250;ltima costela; ponto m&#233;dio entre a crista il&#237;aca e a &#250;ltima costela e imediatamente acima da crista il&#237;aca) em 111 indiv&#237;duos. Em ambos os sexos, foram encontradas diferen&#231;as, mostrando que os quatro locais n&#227;o s&#227;o id&#234;nticos. </p>
    <p>Diversos estudos t&#234;m avaliado a rela&#231;&#227;o entre o PC e a RI. Em um trabalho realizado com 8.400 indiv&#237;duos, o PC associou-se de forma positiva e independente ao diabete tipo 2<sup>30</sup>. No trabalho de Weidner e cols.<sup>31</sup>, o PC foi a primeira vari&#225;vel antropom&#233;trica na an&#225;lise de regress&#227;o multivariada, contribuindo com aproximadamente 37% para uma varia&#231;&#227;o na sensibilidade &#224; insulina. Em um estudo caso-controle realizado com 300 indianos, o PC foi identificado como o preditor mais acurado de risco para diabete tipo 2 e seus indicadores bioqu&#237;micos<sup>32</sup>.</p>
    <p>Em um trabalho conduzido com caucasianos, o PC foi identificado como forte preditor de RI, especialmente nos homens. Foram avaliados os melhores pontos de corte de PC para a predi&#231;&#227;o da RI, sendo 97,5 cm e 106,5 cm os valores encontrados para as mulheres e homens, respectivamente. Contudo, quando comparados aos valores de 88 cm para as mulheres e de 102 cm para os homens, recomendados pelo NCEP-ATP III<sup>23</sup>, os novos pontos de corte n&#227;o se mostraram superiores em identificar indiv&#237;duos com RI<sup>33</sup>.</p>
    <p>No estudo de Pouliot e cols.<sup>19</sup>, o incremento nas medidas de PC foi consistente ao aumento na glicemia e insulinemia de jejum e p&#243;s-prandial, especialmente nas mulheres, sugerindo que essas medidas s&#227;o indicadores do risco cardiovascular. Os autores sugerem que valores de PC acima de 100 cm est&#227;o relacionados &#224; maior chance de desenvolvimento de complica&#231;&#245;es metab&#243;licas.</p>
    <p>
      <bold>Di&#226;metro abdominal sagital</bold>
    </p>
    <p>O di&#226;metro abdominal sagital (DAS) representa a altura abdominal, compreendendo a dist&#226;ncia entre as costas e o abd&#244;men<sup>34</sup>. Pode ser aferido com o indiv&#237;duo de p&#233;<sup>35</sup> ou na posi&#231;&#227;o supina (<xref ref-type="fig" rid="fig2">Figura 2</xref>), sendo esta &#250;ltima a posi&#231;&#227;o mais utilizada<sup>7,35,36</sup>.</p>
    <fig id="fig2">
      <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf02.jpg"/></fig>
    <p>Na posi&#231;&#227;o supina, o tecido adiposo visceral tende a elevar a parede abdominal na dire&#231;&#227;o sagital, e o tecido adiposo abdominal subcut&#226;neo anterior ou lateral comprime o abd&#244;men, ou tende a descer para os lados devido &#224; for&#231;a da gravidade. Assim, espera-se que o DAS aferido na posi&#231;&#227;o supina reflita principalmente o volume de tecido adiposo visceral<sup>37</sup>.</p>
    <p>O local anat&#244;mico utilizado para a aferi&#231;&#227;o diverge entre os estudos, sendo utilizada a menor cintura entre o t&#243;rax e o quadril<sup>38</sup>; a maior altura abdominal<sup>39</sup>; a cicatriz umbilical<sup>40</sup> o ponto m&#233;dio entre a &#250;ltima costela e a crista il&#237;aca<sup>36</sup>; e o ponto m&#233;dio entre as cristas il&#237;acas<sup>41</sup>. Este &#250;ltimo coincide com a localiza&#231;&#227;o das v&#233;rtebras lombares L4 e L5, o local mais utilizado pelas t&#233;cnicas de imagem para quantifica&#231;&#227;o da &#225;rea de tecido adiposo visceral e, talvez, o mais indicado para a aferi&#231;&#227;o do DAS<sup>42</sup>. </p>
    <p>A mensura&#231;&#227;o do DAS pode ser realizada por antropometria com o aux&#237;lio de um <italic>caliper</italic> abdominal, ou por t&#233;cnicas de imagem, como a tomografia computadorizada ou a imagem de resson&#226;ncia magn&#233;tica, pois v&#225;rios estudos demonstraram forte correla&#231;&#227;o entre ambas as t&#233;cnicas<sup>36,43</sup>. </p>
    <p>O DAS tem sido recomendado como indicador de deposi&#231;&#227;o de gordura abdominal visceral e de avalia&#231;&#227;o do risco cardiovascular<sup>44,45</sup>. Recentemente, foram propostos pontos de corte para a avalia&#231;&#227;o do DAS em brasileiros baseados em uma quantidade de gordura abdominal visceral elevada, correspondente a valor superior a 100 cm&#178;. Para o sexo feminino e masculino, os pontos de corte foram 19,3 e 20,5 cm, respectivamente<sup>20</sup>.</p>
    <p>O DAS tem mostrado forte associa&#231;&#227;o com a intoler&#226;ncia &#224; glicose e &#224; RI. Gustat e cols.<sup>38</sup> identificaram o DAS como preditor independente de glicemia e insulinemia, apontando essa medida antropom&#233;trica como excelente marcador de RI. </p>
    <p>No estudo de Ris&#233;rus e cols.<sup>7</sup>, o DAS apresentou correla&#231;&#227;o mais forte com RI, glicemia, insulinemia, pept&#237;deo C e hiperproinsulinemia que o IMC, o PC e a RCQ. Na an&#225;lise de regress&#227;o m&#250;ltipla univariada, incluindo todas as vari&#225;veis antropom&#233;tricas, o DAS foi o &#250;nico preditor independente de RI. No estudo de Petersson e cols.<sup>44</sup>, conduzido com mulheres suecas, o DAS tamb&#233;m foi o melhor marcador cl&#237;nico de RI entre os demais, incluindo o PC, a RCQ e o IMC. No estudo de Pouliot e cols.<sup>19</sup>, al&#233;m do PC, o incremento no DAS tamb&#233;m foi consistente ao aumento na glicemia e insulinemia de jejum e p&#243;s-prandial. Nesse trabalho, valores de DAS acima de 25 cm estavam associados &#224; maior probabilidade de desenvolvimento de dist&#250;rbios metab&#243;licos com potencial aterog&#234;nico.</p>
    <p>
      <bold>Rela&#231;&#227;o cintura/quadril</bold>
    </p>
    <p>A rela&#231;&#227;o cintura/quadril (RCQ) &#233; o &#237;ndice de distribui&#231;&#227;o regional da gordura corporal mais utilizado na pesquisa epidemiol&#243;gica. Baseia-se na raz&#227;o entre os valores de PC e o per&#237;metro do quadril (PQ). O local anat&#244;mico mais utilizado para a aferi&#231;&#227;o do PQ &#233; na altura do grande trocanter, recomendado pela OMS<sup>25</sup>. O PC e o PQ refletem diferentes aspectos da composi&#231;&#227;o corporal e possuem efeitos independentes e opostos na determina&#231;&#227;o do risco de doen&#231;as cardiovasculares e seus fatores de risco. Cinturas estreitas e quadris largos est&#227;o associados &#224; prote&#231;&#227;o contra doen&#231;as cardiovasculares. Essa rela&#231;&#227;o tem sido explicada pela seguinte teoria: quadris estreitos refletem uma quantidade reduzida de massa muscular, o que contribui para menor atividade da insulina na musculatura esquel&#233;tica e para menor concentra&#231;&#227;o e atividade da lipase lipoprot&#233;ica nos m&#250;sculos, com concomitante redu&#231;&#227;o na capta&#231;&#227;o e utiliza&#231;&#227;o dos &#225;cidos graxos pelas c&#233;lulas musculares. Em contrapartida, quadris largos apresentam maior concentra&#231;&#227;o da lipase lipoprot&#233;ica devido &#224; maior quantidade de tecido muscular. Al&#233;m do mais, h&#225; menor <italic>turnover</italic> de &#225;cidos graxos no tecido adiposo gluteofemoral em rela&#231;&#227;o ao tecido adiposo visceral, o que favorece a sensibilidade insul&#237;nica. Contudo, os efeitos independentes de cada um dos per&#237;metros podem ser confundidos na RCQ, sendo a interpreta&#231;&#227;o de seus valores bem mais complexa<sup>46</sup>.</p>
    <p>A RCQ &#233; parcialmente independente da adiposidade total. Indiv&#237;duos magros e obesos podem apresentar o mesmo valor de RCQ, mesmo havendo varia&#231;&#227;o inter-individual substancial na massa gorda total e nas &#225;reas de tecido adiposo abdominal visceral e subcut&#226;neo<sup>19</sup>. Al&#233;m do mais, a RCQ pode se manter inalterada mesmo quando ocorrem modifica&#231;&#245;es na adiposidade corporal devido a altera&#231;&#245;es semelhantes em ambos os per&#237;metros, que n&#227;o alteram a rela&#231;&#227;o final. Dessa forma, &#233; importante ter cautela ao utilizar a RCQ como um indicador do ac&#250;mulo de gordura visceral, sendo essa rela&#231;&#227;o inapropriada para avaliar mudan&#231;as na quantidade de gordura visceral durante a perda ou ganho de peso<sup>47</sup>.</p>
    <p>No estudo de Pouliot e cols.<sup>19</sup>, embora a RCQ n&#227;o tenha sido a melhor preditora de dist&#250;rbios no metabolismo da glicose e da insulina, os autores sugeriram que valores de RCQ acima de 0,8 para as mulheres e de 1,0 para os homens estariam associados a essas altera&#231;&#245;es metab&#243;licas. </p>
    <p>Nos trabalhos de Riserus e cols.<sup>7</sup>, Mamtani e cols.<sup>32</sup> e Petterson e cols.<sup>44</sup>, a RCQ apresentou-se como um instrumento menos &#250;til para predizer a RI, comparada &#224;s demais medidas antropom&#233;tricas estudadas. </p>
    <p>
      <bold>&#205;ndice sagital</bold>
    </p>
    <p>Embora menos conhecido e utilizado entre os pesquisadores e os profissionais de sa&#250;de, o &#237;ndice sagital (IS) foi proposto como uma alternativa &#224; RCQ para a estimativa da distribui&#231;&#227;o de gordura corporal e para a predi&#231;&#227;o de morbidades. O IS &#233; representado pela raz&#227;o entre o DAS (cm) e o per&#237;metro m&#233;dio da coxa (cm). Para us&#225;-lo, partiu-se do princ&#237;pio de que o DAS e o per&#237;metro m&#233;dio da coxa, aferido no ponto m&#233;dio entre a dobra inguinal e a borda proximal da patela (<xref ref-type="fig" rid="fig3">Figura 3</xref>), seriam medidas com melhor representatividade dos tecidos de interesse, comparadas ao PC e ao PQ, respectivamente<sup>47</sup>. </p>
    <fig id="fig3">
      <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf03.jpg"/></fig>
    <p>A medida do per&#237;metro m&#233;dio da coxa compreende a musculatura esquel&#233;tica, o f&#234;mur e o tecido adiposo subcut&#226;neo e intramuscular. Esses tr&#234;s tecidos s&#227;o an&#225;logos aos que circundam o conte&#250;do intra-abdominal, composto pela musculatura esquel&#233;tica, pelas v&#233;rtebras e pelo tecido adiposo subcut&#226;neo. Como o tecido adiposo visceral &#233; o compartimento abdominal de interesse, o per&#237;metro m&#233;dio da coxa representa uma medida de compara&#231;&#227;o com as medidas abdominais<sup>47</sup>. Como vantagem, ao contr&#225;rio do PQ, o per&#237;metro m&#233;dio da coxa n&#227;o &#233; afetado por varia&#231;&#245;es na arquitetura p&#233;lvica. Al&#233;m do mais, o per&#237;metro m&#233;dio da coxa e o DAS s&#227;o medidas com elevada precis&#227;o<sup>34</sup>. O ponto m&#233;dio da coxa &#233; o mais utilizado por representar a por&#231;&#227;o central do m&#250;sculo, que reflete a massa muscular e a pr&#225;tica de exerc&#237;cio f&#237;sico. Indiv&#237;duos com elevado conte&#250;do de massa muscular e tecido adiposo subcut&#226;neo na coxa podem apresentar maior resposta &#224; sinaliza&#231;&#227;o da insulina e menor risco cardiovascular<sup>47</sup>. </p>
    <p>Em estudo realizado no Brasil, o IS apresentou menor correla&#231;&#227;o com o tecido adiposo visceral do que o DAS, no entanto n&#227;o houve correla&#231;&#227;o do IS com a &#225;rea de gordura abdominal subcut&#226;nea<sup>20</sup>. No estudo de Kahn e cols.<sup>48</sup>, entre as medidas antropom&#233;tricas tradicionais, como o IMC e a RCQ, o IS foi o melhor preditor de morte coron&#225;ria s&#250;bita em homens. Smith e cols.<sup>49</sup> avaliaram a for&#231;a da associa&#231;&#227;o de seis par&#226;metros antropom&#233;tricos com conhecidos fatores de risco cardiovascular em homens de diferentes etnias. O IS foi o que apresentou maior <italic>odds ratio</italic> para o risco de doen&#231;a cardiovascular. Embora esses trabalhos tenham apresentado bons resultados para o IS, estudos avaliando a sua utilidade em predizer a RI e demais fatores de risco cardiovascular ainda s&#227;o escassos. </p>
    <p>
      <bold>Rela&#231;&#227;o cintura/coxa</bold>
    </p>
    <p>A rela&#231;&#227;o cintura/coxa (RCCoxa) apresenta fundamenta&#231;&#227;o semelhante &#224; aplicada ao IS no que diz respeito &#224;s vantagens da utiliza&#231;&#227;o do per&#237;metro da coxa em detrimento do PQ, sendo calculada a partir da raz&#227;o entre os valores de PC (cm) e o per&#237;metro m&#233;dio da coxa (cm). </p>
    <p>No estudo de Chuang e cols.<sup>8</sup>, com orientais (n = 6.007), entre as 32 medidas avaliadas por meio de um <italic>scanning </italic>a laser em tr&#234;s dimens&#245;es, o PC, representando o tronco, e o per&#237;metro m&#233;dio da coxa, representando a parte inferior do corpo, foram os melhores indicadores de diabete tipo 2. Ao comparar a RCCoxa com indicadores antropom&#233;tricos conhecidos, entre eles o IMC, a RCQ e o PC, os autores identificaram correla&#231;&#245;es mais fortes para a RCCoxa. No estudo de Kahn e cols. <sup>48</sup>, a RCCoxa apresentou bom desempenho para a avalia&#231;&#227;o do risco de doen&#231;a cardiovascular, paralelamente ao IS.</p>
    <p>
      <bold>Rela&#231;&#227;o pesco&#231;o/coxa</bold>
    </p>
    <p>A rela&#231;&#227;o pesco&#231;o/coxa (RPCoxa) compreende a raz&#227;o entre o per&#237;metro do pesco&#231;o (cm), aferido no ponto m&#233;dio da altura do pesco&#231;o (<xref ref-type="fig" rid="fig4">Figura 4</xref>), e o per&#237;metro m&#233;dio da coxa (cm), os quais t&#234;m sido usados como &#237;ndices de distribui&#231;&#227;o do tecido adiposo subcut&#226;neo das regi&#245;es corporais superior e inferior, respectivamente. Seguindo o modelo de composi&#231;&#227;o corporal tricompartimental (tecido adiposo subcut&#226;neo e visceral e massa magra), ap&#243;s ajuste para massa magra e para tecido adiposo visceral, Sj&#246;str&#246;m e cols. identificaram correla&#231;&#227;o positiva entre o per&#237;metro do pesco&#231;o e fatores de risco cardiovascular relacionados &#224; RI, enquanto o per&#237;metro da coxa apresentou correla&#231;&#227;o inversa<sup>50</sup>.</p>
    <fig id="fig4">
      <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf04.jpg"/></fig>
    <p>Laakso e cols.<sup>51</sup>, em estudo realizado com 541 adultos distribu&#237;dos segundo quintis do per&#237;metro do pesco&#231;o, identificaram maiores frequ&#234;ncias de hiperglicemia e hiperinsulinemia nos quintis superiores da medida, sugerindo a utiliza&#231;&#227;o do per&#237;metro do pesco&#231;o, em <italic>screenings</italic> populacionais, como indicador de indiv&#237;duos em risco para RI. Ben-Noun e Laor<sup>52</sup> tamb&#233;m encontraram correla&#231;&#227;o significante entre o per&#237;metro do pesco&#231;o com diversos fatores de risco cardiovascular relacionados &#224; RI. </p>
    <p>Embora os trabalhos avaliando a RPCoxa sejam raros, ressalta-se que o per&#237;metro do pesco&#231;o representa uma medida r&#225;pida e f&#225;cil de ser realizada, al&#233;m de n&#227;o apresentar varia&#231;&#245;es em sua magnitude ao longo do dia.</p>
    <p>
      <bold>Rela&#231;&#227;o cintura/estatura</bold>
    </p>
    <p>A rela&#231;&#227;o cintura/estatura (RCE) compreende a raz&#227;o entre o PC (cm) e a estatura (cm). Ela baseia-se no pressuposto de que, para determinada estatura, h&#225; um grau aceit&#225;vel de gordura armazenada na por&#231;&#227;o superior do corpo. Embora o efeito preciso da estatura sobre a medida do PC seja quantitativamente desconhecido, alguns autores afirmam que a estatura exerce influ&#234;ncia na magnitude do PC ao longo do crescimento e tamb&#233;m na vida adulta<sup>53,54</sup>. </p>
    <p>Trabalhos apontam que, al&#233;m de a RCE apresentar boa correla&#231;&#227;o com a gordura visceral, ela deveria ser o indicador antropom&#233;trico utilizado para a predi&#231;&#227;o de riscos metab&#243;licos associados &#224; obesidade<sup>17,54</sup>. O argumento mais utilizado &#233; que o PC<sup>54</sup> e o IMC<sup>55</sup> necessitam de diversos pontos de corte dependendo da etnia e/ou do g&#234;nero<sup>22,25</sup>, o que supostamente dificultaria sua utiliza&#231;&#227;o. Segundo esses autores, a manuten&#231;&#227;o do valor do PC abaixo do valor correspondente &#224; metade da estatura representaria uma mensagem simples e efetiva para toda a popula&#231;&#227;o, de modo a auxiliar na preven&#231;&#227;o da s&#237;ndrome de RI<sup>54,55</sup>. Em um estudo realizado com homens iranianos, a RCE apresentou melhor desempenho em predizer o diabete tipo 2 comparada ao IMC<sup>9</sup>.</p>
    <p>Entre as vantagens da RCE estaria sua rela&#231;&#227;o com os fatores de risco cardiovascular, incluindo a insulinemia de jejum<sup>17</sup>; a elevada sensibilidade em detectar fatores de risco precocemente, quando comparada ao IMC; e a simplicidade de execu&#231;&#227;o aliada &#224; facilidade de um &#250;nico ponto de corte para classifica&#231;&#227;o dos indiv&#237;duos, em que o valor de 0,5, determinado com base no balan&#231;o &#243;timo entre sensibilidade e especificidade, poderia ser utilizado universalmente<sup>55,56</sup>. O estudo de Ho e cols. <sup>17</sup> encontrou o valor de 0,48 como melhor ponto de corte para predizer hiperinsulinemia em homens chineses.</p>
    <p>Apesar da RCE utilizar a estatura e permitir sua aplica&#231;&#227;o em diversas etnias, pode-se questionar se o distinto padr&#227;o de distribui&#231;&#227;o de gordura corporal entre homens e mulheres dificultaria a utiliza&#231;&#227;o de um &#250;nico ponto de corte para ambos os sexos. Por&#233;m, os homens s&#227;o mais altos e apresentam maiores medidas de PC em rela&#231;&#227;o &#224;s mulheres. Dessa forma, as m&#233;dias de RCE s&#227;o semelhantes para ambos os sexos devido ao ajuste para a estatura<sup>54</sup>.</p>
    <p>
      <bold>&#205;ndice de conicidade</bold>
    </p>
    <p>Proposto por Valdez<sup>57</sup>, o &#237;ndice de conicidade (I&#231;O) representa um indicador de obesidade abdominal. Ele considera que indiv&#237;duos com menor ac&#250;mulo de gordura na regi&#227;o central teriam a forma corporal semelhante &#224; de um cilindro, enquanto aqueles com maior ac&#250;mulo se assemelhariam a um duplo cone, tendo este uma base em comum. </p>
    <p>A equa&#231;&#227;o do ICO leva em considera&#231;&#227;o as medidas de PC, peso corporal, estatura e a constante de 0,109, que representa a convers&#227;o das unidades de volume e massa para as unidades de comprimento<sup>58</sup>:</p>
    <p>
      <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-e01.jpg"/></p>
    <p>O ICO &#233; de interpreta&#231;&#227;o simples, uma vez que o denominador corresponde ao cilindro produzido pelo peso e pela estatura do avaliado. Dessa forma, um ICO igual a 1,20 significa que o PC &#233; 1,20 vez maior do que o per&#237;metro do cilindro gerado a partir do peso e da estatura daquela pessoa, refletindo o excesso de adiposidade na regi&#227;o abdominal. O ICO n&#227;o apresenta unidade de medida e sua faixa te&#243;rica &#233; de 1,00 (cilindro perfeito) a 1,73 (cone duplo)<sup>58</sup>.</p>
    <p>Entre suas vantagens, est&#225; o fato de incluir em sua estrutura um ajuste do PC para peso e estatura, permitindo compara&#231;&#245;es diretas de adiposidade abdominal entre os indiv&#237;duos ou entre as popula&#231;&#245;es. Al&#233;m do mais, o ICO apresenta fraca correla&#231;&#227;o com a estatura, o que &#233; desej&#225;vel para qualquer indicador de obesidade<sup>57,58</sup>. </p>
    <p>Em um estudo multic&#234;ntrico, reunindo 2.240 adultos, a insulinemia apresentou padr&#245;es de correla&#231;&#227;o consistentes com o ICO<sup>58</sup>. Pitanga e Lessa<sup>6</sup> conduziram um trabalho no Brasil com 2.297 indiv&#237;duos e identificaram o ICO como discriminador de glicemia e de risco cardiovascular. Esses autores desenvolveram uma tabela para facilitar a utiliza&#231;&#227;o do ICO, na qual, a partir dos valores de peso e estatura tem-se o denominador do &#237;ndice j&#225; calculado. Dessa forma, a conicidade de qualquer valor de cintura, para dado peso e dada estatura, pode ser prontamente analisada, possibilitando prognosticar os riscos de doen&#231;as associadas &#224; adiposidade abdominal, como a RI.</p>
    <p>Em contrapartida, no estudo de Mantzoros e cols.<sup>59</sup>, realizado na Gr&#233;cia, com 280 mulheres saud&#225;veis de 18 a 24 anos, o ICO apresentou correla&#231;&#227;o muito fraca (r = 0,13, p = 0,03) com a insulinemia de jejum. Mamtani e Kuljarni<sup>32</sup>, comparando o desempenho de diversos par&#226;metros antropom&#233;tricos relacionados &#224; obesidade central, verificaram que o ICO foi o par&#226;metro que apresentou menor acur&#225;cia preditiva para as medidas de obesidade central. Nesse mesmo estudo, o ICO n&#227;o apresentou correla&#231;&#227;o com as glicemias de jejum e p&#243;s-prandial. Assim, observa-se a necessidade de mais investiga&#231;&#245;es acerca desse &#237;ndice para determinar sua viabilidade na predi&#231;&#227;o do risco de RI. </p>
    <p>
      <bold>&#205;ndice de massa corporal</bold>
    </p>
    <p>O &#237;ndice de massa corporal (IMC) &#233; calculado a partir da raz&#227;o entre o peso corporal (kg) e a estatura (m) elevada ao quadrado<sup>60</sup>. Ele representa o indicador do estado nutricional mais conhecido e utilizado para avalia&#231;&#227;o de adultos e idosos, devido &#224; sua facilidade de aplica&#231;&#227;o e ao baixo custo. Caracteriza-se como um indicador de adiposidade generalizada devido &#224; sua incapacidade de avaliar a distribui&#231;&#227;o da gordura corporal. Modifica&#231;&#245;es no IMC n&#227;o refletem o local anat&#244;mico no qual o indiv&#237;duo pode ter perdido ou ganhado peso<sup>61</sup>. De forma geral, observa-se que o IMC apresenta correla&#231;&#245;es mais fracas com a gordura visceral do que o PC e o DAS<sup>20,43</sup>.</p>
    <p>Os trabalhos que avaliaram a capacidade do IMC em predizer RI v&#234;m apresentando resultados contradit&#243;rios. No estudo de Farin e cols.<sup>62</sup> n&#227;o houve diferen&#231;a na magnitude das correla&#231;&#245;es entre o IMC e o PC com a RI em caucasianos. A partir da an&#225;lise de regress&#227;o, ambos os indicadores de adiposidade generalizada e central apresentaram a mesma capacidade de identificar indiv&#237;duos com RI. No trabalho de Ascaso e cols.<sup>63</sup>, conduzido com espanh&#243;is, tanto o PC como o IMC correlacionaram-se com a RI. Na an&#225;lise de regress&#227;o log&#237;stica, apenas o IMC permaneceu no modelo com uma <italic>odds ratio</italic> de 2,6, enquanto o PC perdeu signific&#226;ncia estat&#237;stica. Chang e cols.<sup>64</sup> identificaram o IMC como o determinante mais importante de RI em orientais. Todavia, as correla&#231;&#245;es entre IMC e RI foram fracas e esse foi o &#250;nico indicador antropom&#233;trico utilizado no estudo. Ybarra e cols.<sup>33</sup> afirmaram que os melhores pontos de corte de IMC para predizer a RI s&#227;o valores a partir de 29,5 kg/m&#178; para as mulheres e de 30,5 kg/m&#178; para os homens. Observa-se que tais pontos de corte se assemelham ao valor de 30 kg/m&#178; proposto pela Organiza&#231;&#227;o Mundial da Sa&#250;de<sup>25</sup> para a classifica&#231;&#227;o da obesidade. Contudo, vale ressaltar que esse trabalho foi conduzido com espanh&#243;is, n&#227;o podendo ser generalizado &#224;s demais etnias. Stern e cols.<sup>65</sup> avaliaram 2.321 indiv&#237;duos de diversas etnias e identificaram como pontos de corte para predi&#231;&#227;o de RI valores de IMC &gt; 28,7 kg/m&#178;.</p>
    <p>Ainda que os trabalhos citados tenham apontado resultados positivos para o IMC na predi&#231;&#227;o da RI, diversos estudos que avaliaram medidas de adiposidade central<sup>7,17,44,54,66</sup>, ou de distribui&#231;&#227;o da gordura corporal<sup>8,17</sup>, mostraram a superioridade dessas em rela&#231;&#227;o ao IMC, provavelmente devido &#224; associa&#231;&#227;o entre RI e o ac&#250;mulo de tecido adiposo visceral, que &#233; mais bem representado por essas medidas. Al&#233;m do mais, devido &#224; incapacidade do IMC em distinguir entre massa corporal magra e gorda, a sua utiliza&#231;&#227;o para a predi&#231;&#227;o da RI pode superestimar o risco em indiv&#237;duos com elevada quantidade de massa muscular, como atletas, e subestimar o risco em idosos, cuja massa muscular geralmente apresenta-se reduzida e h&#225; ac&#250;mulo aumentado de tecido adiposo visceral<sup>17</sup>.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>A escassez de estudos comparando os diversos indicadores antropom&#233;tricos em um &#250;nico trabalho dificulta a conclus&#227;o de qual &#233; o melhor indicador para a predi&#231;&#227;o de RI. Contudo, o PC e o DAS parecem apresentar melhor capacidade preditiva para a RI, uma vez que os resultados foram mais consistentes entre os trabalhos. A RCCoxa, o ICO, o IS, a RPCoxa e a RCE t&#234;m demonstrado resultados positivos, contudo mais estudos s&#227;o necess&#225;rios para consolid&#225;-los como indicadores de RI. Os resultados do IMC e da RCQ foram mais inconsistentes. Ainda que seja extremamente &#250;til, do ponto de vista cl&#237;nico, identificar os indicadores antropom&#233;tricos de adiposidade que apresentam a melhor capacidade de identificar indiv&#237;duos com RI, &#233; importante considerar que, a partir delas, sempre ser&#225; avaliado o risco, pois s&#227;o m&#233;todos alternativos e que, por si s&#243;, n&#227;o explicam a RI como um todo. Vari&#225;veis importantes de influ&#234;ncia na modula&#231;&#227;o da a&#231;&#227;o da insulina como o estilo de vida e os fatores gen&#233;ticos devem ser levados em considera&#231;&#227;o. </p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>Apoio FAPEMIG e CNPq.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado pelo CNPq e FAPEMIG.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Ana Carolina Junqueira Vasques pela Universidade Federal de Vi&#231;osa.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Ana Carolina Junqueira Vasques </p>
        <p> Laborat&#243;rio LIMED - Gastrocentro - UNICAMP </p>
        <p> Rua Carlos Chagas, 420 </p>
        <p> 13081-970 - Bar&#227;o Geraldo, Campinas, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="anacarolinavasques@yahoo.com.br">anacarolinavasques@yahoo.com.br</email>
        </p>
      </fn>
    </p>
    <p> Artigo recebido em 29/08/08; revisado recebido em 17/03/09; aceito em 11/05/09.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1.&#160;&#160;&#160;Silva EA, Flexa F, Zanella MT. Obesidade    abdominal, resist&#234;ncia &#224; insulina e hipertens&#227;o: impacto    sobre a massa e a fun&#231;&#227;o do ventr&#237;culo esquerdo em mulheres.    Arq Bras Cardiol. 2007; 89 (2): 86-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesidade abdominal, resist&#234;ncia &#224; insulina e hipertens&#227;o: impacto sobre a massa e a fun&#231;&#227;o do ventr&#237;culo esquerdo em mulheres</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>86</fpage>
          <lpage>92</lpage>
          <issue>2</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Flexa</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zanella</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2.&#160; Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke    C, Rundek T, Elkind MV, et al. Metabolic syndrome and ischemic stroke risk:    Northern Manhattan Study. Stroke. 2008; 39 (1): 30-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study</article-title>
          <source>Stroke</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>30</fpage>
          <lpage>5</lpage>
          <issue>1</issue>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Boden-Albala</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sacco</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Grahame-Clarke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rundek</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Elkind</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3.&#160; Ribeiro Filho FF, Mariosa LS, Ferreira SR,    Zanella MT. Gordura visceral e s&#237;ndrome metab&#243;lica: mais que uma    simples associa&#231;&#227;o. Arq Bras Endocrinol Metab. 2006; 50 (2): 230-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Gordura visceral e s&#237;ndrome metab&#243;lica: mais que uma simples associa&#231;&#227;o</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>230</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro Filho</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Mariosa</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Zanella</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4.&#160; Vasques ACJ, Rosado LEFPL, Alfenas RCG, Geloneze    B. An&#225;lise cr&#237;tica do uso dos &#237;ndices do Homeostasis Model    Assessment (HOMA) na avalia&#231;&#227;o da resist&#234;ncia &#224; insulina    e capacidade funcional das c&#233;lulas-b pancre&#225;ticas. Arq Bras Endocrinol    Metab. 2008; 52 (1): 32-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An&#225;lise cr&#237;tica do uso dos &#237;ndices do Homeostasis Model Assessment (HOMA) na avalia&#231;&#227;o da resist&#234;ncia &#224; insulina e capacidade funcional das c&#233;lulas-b pancre&#225;ticas</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>32</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vasques</surname>
              <given-names>ACJ</given-names>
            </name>
            <name>
              <surname>Rosado</surname>
              <given-names>LEFPL</given-names>
            </name>
            <name>
              <surname>Alfenas</surname>
              <given-names>RCG</given-names>
            </name>
            <name>
              <surname>Geloneze</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5.&#160; Taniguchi A, Fukushima M, Sakai M, Kataoka    K, Nagata I, Doi K, et al. The role of the body mass index and triglyceride    levels in identifying insulin-sensitive and insulin-resistant variants in Japanese    non-insulin-dependent diabetic patients. Metabolism. 2000; 49 (8): 1001-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients</article-title>
          <source>Metabolism</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1001</fpage>
          <lpage>5</lpage>
          <issue>8</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kataoka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6.&#160; Pitanga FJG, Lessa I. Sensibilidade e especificidade    do &#237;ndice de conicidade como discriminador do risco coronariano de adultos    em Salvador, Brasil. Rev Bras Epidemiol. 2004; 7 (3): 259-69.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sensibilidade e especificidade do &#237;ndice de conicidade como discriminador do risco coronariano de adultos em Salvador, Brasil</article-title>
          <source>Rev Bras Epidemiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>259</fpage>
          <lpage>69</lpage>
          <issue>3</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pitanga</surname>
              <given-names>FJG</given-names>
            </name>
            <name>
              <surname>Lessa</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7.&#160; Riserus U, Arnlov J, Brismar K, Zethelius    B, Berglund L, Vessby B. Sagittal abdominal diameter is a strong anthropometric    marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes    Care. 2004; 27 (8): 2041-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2041</fpage>
          <lpage>6</lpage>
          <issue>8</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Riserus</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Arnlov</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brismar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zethelius</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Berglund</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vessby</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8.&#160; Chuang YC, Hsu KH, Hwang CJ, Hu PM, Lin TM,    Chiou WK. Waist-to-thigh ratio can also be a better indicator associated with    type 2 diabetes than traditional anthropometrical measurements in Taiwan population.    Ann Epidemiol. 2006; 16 (5): 321-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist-to-thigh ratio can also be a better indicator associated with type 2 diabetes than traditional anthropometrical measurements in Taiwan population</article-title>
          <source>Ann Epidemiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>321</fpage>
          <lpage>31</lpage>
          <issue>5</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chuang</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Chiou</surname>
              <given-names>WK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9.&#160; Meshkani R, Taghikhani M, Larijani B, Khatami    S, Khoshbin E, Adeli K. The relationship between homeostasis model assessment    and cardiovascular risk factors in Iranian subjects with normal fasting glucose    and normal glucose tolerance. Clin Chim Acta. 2006; 371 (1-2): 169-75 </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance</article-title>
          <source>Clin Chim Acta</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>169</fpage>
          <lpage>75</lpage>
          <issue>1-2</issue>
          <volume>371</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Meshkani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Taghikhani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Larijani</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Khatami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khoshbin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Adeli</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Geloneze B, Tambascia MA. Avalia&#231;&#227;o    laboratorial e diagn&#243;stico de resist&#234;ncia insul&#237;nica. Arq    Bras Endocrinol Metab. 2006; 50 (2): 208-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Avalia&#231;&#227;o laboratorial e diagn&#243;stico de resist&#234;ncia insul&#237;nica</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>208</fpage>
          <lpage>15</lpage>
          <issue>2</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Geloneze</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tambascia</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. DeFronzo RA, Tobin JD, Andres R. Glucose    clamp technique: a method for quantifying insulin secretion and resistance.    Am J Physiol. 1979; 237 (3): 214-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Glucose clamp technique: a method for quantifying insulin secretion and resistance</article-title>
          <source>Am J Physiol</source>
          <date>
            <year>1979</year>
          </date>
          <fpage>214</fpage>
          <lpage>23</lpage>
          <issue>3</issue>
          <volume>237</volume>
          <person-group person-group-type="author">
            <name>
              <surname>DeFronzo</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Tobin</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Andres</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Matthews DR, Hosker JP, Rudenski AS, Naylor    BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance    and beta-cell function from fasting plasma glucose and insulin concentrations    in man. Diabetologia. 1985; 28 (7): 412-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title>
          <source>Diabetologia</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>412</fpage>
          <lpage>9</lpage>
          <issue>7</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Matthews</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Hosker</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Rudenski</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Naylor</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Treacher</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Hermans MP, Pepersack TM, Godeaux LH, Beyer    I, Turc AP. Prevalence and determinants of impaired glucose metabolism in frail    elderly patients: the Belgian Elderly Diabetes Survey (BEDS). J Gerontol A Biol    Sci Med Sci. 2005; 60 (2): 241-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence and determinants of impaired glucose metabolism in frail elderly patients: the Belgian Elderly Diabetes Survey (BEDS)</article-title>
          <source>J Gerontol A Biol Sci Med Sci</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>241</fpage>
          <lpage>7</lpage>
          <issue>2</issue>
          <volume>60</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hermans</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Pepersack</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Godeaux</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Beyer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Turc</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Bonora E, Targher G, Alberiche M, Bonadonna    RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors    the glucose clamp technique in the assessment of insulin sensitivity: studies    in subjects with various degrees of glucose tolerance and insulin sensitivity.    Diabetes Care. 2000; 23 (1): 57-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>57</fpage>
          <lpage>63</lpage>
          <issue>1</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bonora</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Targher</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alberiche</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bonadonna</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Saggiani</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zenere</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Ross R. Advances in the application of imaging    methods in applied and clinical physiology. Acta Diabetol. 2003; 40 (Suppl 1):    45-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Advances in the application of imaging methods in applied and clinical physiology</article-title>
          <source>Acta Diabetol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>45</fpage>
          <lpage>50</lpage>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Leite CC, Matsuda D, Wajchenberg BL, Cerri    GG, Halpern A. Correla&#231;&#227;o da medida de espessura intra-abdominal    medida pela ultra-sonografia com os fatores de risco cardiovascular. Arq Bras    Endocrinol Metab. 2000; 44 (1): 49-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Correla&#231;&#227;o da medida de espessura intra-abdominal medida pela ultra-sonografia com os fatores de risco cardiovascular</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>49</fpage>
          <lpage>56</lpage>
          <issue>1</issue>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leite</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wajchenberg</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Cerri</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Ho SY, Lam TH, Janus ED. Waist to stature    ratio is more strongly associated with cardiovascular risk factors than other    simple anthropometric indices. Ann Epidemiol. 2003; 13 (10): 683-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist to stature ratio is more strongly associated with cardiovascular risk factors than other simple anthropometric indices</article-title>
          <source>Ann Epidemiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>683</fpage>
          <lpage>91</lpage>
          <issue>10</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Janus</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge    M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and behavioral characteristics    of metabolically obese but normal-weight women. J Clin Endocrinol Metab. 2004;    89 (10): 5013-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic and behavioral characteristics of metabolically obese but normal-weight women</article-title>
          <source>J Clin Endocrinol Metab</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>5013</fpage>
          <lpage>20</lpage>
          <issue>10</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Conus</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Allison</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Rabasa-Lhoret</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>St-Onge</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>St-Pierre</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Tremblay-Lebeau</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Pouliot MC, Despres JP, Lemieux S, Moorjani    S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal    diameter: best simple anthropometric indexes of abdominal visceral adipose tissue    accumulation and related cardiovascular risk in men and women. Am J Cardiol.    1994; 73 (7): 460-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>460</fpage>
          <lpage>8</lpage>
          <issue>7</issue>
          <volume>73</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pouliot</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Despres</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lemieux</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moorjani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Sampaio LR, Simoes EJ, Assis AM, Ramos LR.    Validade e confiabilidade do di&#226;metro abdominal sagital enquanto preditor    de gordura abdominal visceral. Arq Bras Endocrinol Metab. 2007; 51 (6): 980-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Validade e confiabilidade do di&#226;metro abdominal sagital enquanto preditor de gordura abdominal visceral</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>980</fpage>
          <lpage>6</lpage>
          <issue>6</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sampaio</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Simoes</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Assis</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Balkau B, Charles MA. Comment on the provisional    report from the WHO consultation. European Group for the Study of Insulin Resistance    (EGIR). Diabet Med. 1999; 16 (5): 442-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR)</article-title>
          <source>Diabet Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>442</fpage>
          <lpage>3</lpage>
          <issue>5</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Balkau</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Charles</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a    new world-wide definition. A Consensus Statement from the International Diabetes    Federation. Diabet Med. 2006; 23 (5): 469-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome--a new world-wide definition: A Consensus Statement from the International Diabetes Federation</article-title>
          <source>Diabet Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>469</fpage>
          <lpage>80</lpage>
          <issue>5</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alberti</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Zimmet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Expert Panel on Detection, Evaluation, and    Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third    Report of The National Cholesterol Education Program (NCEP) Expert Panel on    Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult    Treatment Panel III). JAMA. 2001; 285 (19): 2486-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)</article-title>
          <source>JAMA</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2486</fpage>
          <lpage>97</lpage>
          <issue>19</issue>
          <volume>285</volume>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Han TS, van Leer EM, Seidell JC, Lean ME.    Waist circumference action levels in the identification of cardiovascular risk    factors: prevalence study in a random sample. BMJ. 1995; 311: 1401-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample</article-title>
          <source>BMJ</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1401</fpage>
          <lpage>5</lpage>
          <volume>311</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>van Leer</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lean</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: WHO Technical Report Series 894. World Health Organization, 2000.</mixed-citation>
        <element-citation publication-type="book">
          <source>Obesity: preventing and managing the global epidemic</source>
          <date>
            <year>2000</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Lohman TG, Roche AF, Martorell R. Anthropometric    standardization reference manual. Champaign: Human Kinetics Pub; 1988.</mixed-citation>
        <element-citation publication-type="book">
          <source>Anthropometric standardization reference manual</source>
          <date>
            <year>1988</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Lohman</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Roche</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Martorell</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27. National Institute of Health (NIH). The practical guide identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: NIH; 2000.</mixed-citation>
        <element-citation publication-type="book">
          <source>The practical guide identification, evaluation, and treatment of overweight and obesity in adults</source>
          <date>
            <year>2000</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Ross R, Berentzen T, Bradshaw AJ, Jansson    I, Kahn HS, Katzmarzyk PT, et al. Does the relationship between waist circumference,    morbidity and mortality depend on measurement protocol for waist circumference?    Obes Rev. 2007; 9 (4): 312-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference</article-title>
          <source>Obes Rev</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>312</fpage>
          <lpage>25</lpage>
          <issue>4</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Berentzen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bradshaw</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Jansson</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Katzmarzyk</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Wang J, Thornton JC, Bari S, Williamson B,    Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured    at 4 sites. Am J Clin Nutr. 2003; 77 (2): 379-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparisons of waist circumferences measured at 4 sites</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>379</fpage>
          <lpage>84</lpage>
          <issue>2</issue>
          <volume>77</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Heymsfield</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Snijder MB, Zimmet PZ, Visser M, Dekker JM,    Seidell JC, Shaw JE. Independent and opposite associations of waist and hip    circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study.    Int J Obes Relat Metab Disord. 2004; 28 (3): 402-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>402</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Snijder</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Zimmet</surname>
              <given-names>PZ</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dekker</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Weidner MD, Gavigan KE, Tyndall GL, Hickey    MS, McCammon MR, Houmard JA. Which anthropometric indices of regional adiposity    are related to the insulin resistance of aging? Int J Obes Relat Metab Disord.    1995; 19 (5): 325-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Which anthropometric indices of regional adiposity are related to the insulin resistance of aging</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>325</fpage>
          <lpage>30</lpage>
          <issue>5</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weidner</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Gavigan</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Tyndall</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Hickey</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>McCammon</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Houmard</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Mamtani MR, Kulkarni HR. Predictive performance    of anthropometric indexes of central obesity for the risk of type 2 diabetes.    Arch Med Res. 2005; 36 (5): 581-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictive performance of anthropometric indexes of central obesity for the risk of type 2 diabetes</article-title>
          <source>Arch Med Res</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>581</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mamtani</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Ybarra J, Sanchez-Hernandez J, Pou J, Fernandez    S, Gich I, Ordonez-Llamos J, et al. Anthropometrical measures are easily obtainable    sensitive and specific predictors of insulin resistance in healthy individuals.    Prevention and Control. 2005; 1 (2): 175-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Anthropometrical measures are easily obtainable sensitive and specific predictors of insulin resistance in healthy individuals</article-title>
          <source>Prevention and Control</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>175</fpage>
          <lpage>81</lpage>
          <issue>2</issue>
          <volume>1</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ybarra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sanchez-Hernandez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gich</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ordonez-Llamos</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Williamson DF, Kahn HS, Worthman CM, Burnette    JC, Russell CM. Precision of recumbent anthropometry. Am J Hum Biol. 1993; 5    (2): 159-67.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Precision of recumbent anthropometry</article-title>
          <source>Am J Hum Biol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>159</fpage>
          <lpage>67</lpage>
          <issue>2</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Williamson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Worthman</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Burnette</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Iribarren C, Darbinian JA, Lo JC, Fireman    BH, Go AS. Value of the sagittal abdominal diameter in coronary heart disease    risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol.    2006; 164 (12): 1150-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population</article-title>
          <source>Am J Epidemiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1150</fpage>
          <lpage>9</lpage>
          <issue>12</issue>
          <volume>164</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Iribarren</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Darbinian</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Fireman</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Go</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. van der Kooy K, Leenen R, Seidell JC, Deurenberg    P, Visser M. Abdominal diameters as indicators of visceral fat: comparison between    magnetic resonance imaging and anthropometry. Br J Nutr. 1993; 70 (1): 47-58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry</article-title>
          <source>Br J Nutr</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>47</fpage>
          <lpage>58</lpage>
          <issue>1</issue>
          <volume>70</volume>
          <person-group person-group-type="author">
            <name>
              <surname>van der Kooy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Leenen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Deurenberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Sj&#246;strom L. A computer-tomography based multicompartment    body composition technique and anthropometric predictions of lean body mass,    total and subcutaneous adipose tissue. Int J Obes. 1991; 15 (Suppl 2): 19-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue</article-title>
          <source>Int J Obes</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>19</fpage>
          <lpage>30</lpage>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sj&#246;strom</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Gustat J, Elkasabany A, Srinivasan S, Berenson    GS. Relation of abdominal height to cardiovascular risk factors in young adults:    the Bogalusa heart study. Am J Epidemiol. 2000; 151 (9): 885-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study</article-title>
          <source>Am J Epidemiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>885</fpage>
          <lpage>91</lpage>
          <issue>9</issue>
          <volume>151</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gustat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Elkasabany</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Kullberg J, von Below C, Lonn L, Lind L,    Ahlstrom H, Johansson L. Practical approach for estimation of subcutaneous and    visceral adipose tissue. Clin Physiol Funct Imaging. 2007; 27 (3): 148-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Practical approach for estimation of subcutaneous and visceral adipose tissue</article-title>
          <source>Clin Physiol Funct Imaging</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>148</fpage>
          <lpage>53</lpage>
          <issue>3</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kullberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>von Below</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lonn</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lind</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ahlstrom</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Ohrvall M, Berglund L, Vessby B. Sagittal    abdominal diameter compared with other anthropometric measurements in relation    to cardiovascular risk. Int J Obes Relat Metab Disord. 2000; 24 (4): 497-501.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>497</fpage>
          <lpage>501</lpage>
          <issue>4</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ohrvall</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Berglund</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vessby</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B41">
        <mixed-citation>41. Kahn HS, Simoes EJ, Koponen M, Hanzlick R.    The abdominal diameter index and sudden coronary death in men. Am J Cardiol.    1996; 78 (8): 961-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The abdominal diameter index and sudden coronary death in men</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>961</fpage>
          <lpage>4</lpage>
          <issue>8</issue>
          <volume>78</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kahn</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Simoes</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Koponen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hanzlick</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B42">
        <mixed-citation>42. Kahn HS. Alternative anthropometric measures    of risk: possible improvements on the waist-hip ratio. In: Medeiros-Neto G,    Halpern A, Bouchard C. (eds.). Progress in obesity research. 9th ed. London:    John Libbey Eurotext Ltd; 2003 .p. 639-43.</mixed-citation>
        <element-citation publication-type="book">
          <source>Progress in obesity research</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>639</fpage>
          <lpage>43</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Kahn</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Medeiros-Neto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B43">
        <mixed-citation>43. Despres JP, Prud'homme D, Pouliot MC, Tremblay    A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from    simple anthropometric measurements in men. Am J Clin Nutr. 1991; 54 (3): 471-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>471</fpage>
          <lpage>7</lpage>
          <issue>3</issue>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Despres</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Prud'homme</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pouliot</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B44">
        <mixed-citation>44. Petersson H, Daryani A, Riserus U. Sagittal    abdominal diameter as a marker of inflammation and insulin resistance among    immigrant women from the Middle East and native Swedish women: a cross-sectional    study. Cardiovasc Diabetol. 2007; 6: 10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study</article-title>
          <source>Cardiovasc Diabetol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>10</fpage>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Petersson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Daryani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Riserus</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B45">
        <mixed-citation>45. Seidell JC, Perusse L, Despres JP, Bouchard    C. Waist and hip circumferences have independent and opposite effects on cardiovascular    disease risk factors: the Quebec Family Study. Am J Clin Nutr. 2001; 74 (3):    315-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>315</fpage>
          <lpage>21</lpage>
          <issue>3</issue>
          <volume>74</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Perusse</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Despres</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B46">
        <mixed-citation>46. van der Kooy K, Leenen R, Seidell JC, Deurenberg    P, Droop A, Bakker CJ. Waist-hip ratio is a poor predictor of changes in visceral    fat. Am J Clin Nutr. 1993; 57 (3): 327-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Waist-hip ratio is a poor predictor of changes in visceral fat</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>327</fpage>
          <lpage>33</lpage>
          <issue>3</issue>
          <volume>57</volume>
          <person-group person-group-type="author">
            <name>
              <surname>van der Kooy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Leenen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Deurenberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Droop</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B47">
        <mixed-citation>47. Kahn HS. Choosing an index for abdominal    obesity: an opportunity for epidemiologic clarification. J Clin Epidemiol. 1993;    46: 491-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Choosing an index for abdominal obesity: an opportunity for epidemiologic clarification</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>491</fpage>
          <lpage>4</lpage>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kahn</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B48">
        <mixed-citation>48. Kahn HS, Austin H, Williamson DF, Arensberg    D. Simple anthropometric indices associated with ischemic heart disease. J Clin    Epidemiol. 1996; 49 (9): 1017-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Simple anthropometric indices associated with ischemic heart disease</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1017</fpage>
          <lpage>24</lpage>
          <issue>9</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kahn</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Austin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Arensberg</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B49">
        <mixed-citation>49. Smith DA, Ness EM, Herbert R, Schechter CB,    Phillips RA, Diamond JA, et al. Abdominal diameter index: a more powerful anthropometric    measure for prevalent coronary heart disease risk in adult males. Diabetes Obes    Metab. 2005; 7 (4): 370-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Abdominal diameter index: a more powerful anthropometric measure for prevalent coronary heart disease risk in adult males</article-title>
          <source>Diabetes Obes Metab</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>370</fpage>
          <lpage>80</lpage>
          <issue>4</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Ness</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schechter</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B50">
        <mixed-citation>50. Sj&#246;str&#246;m CD, H&#314;kang&#314;rd AC, Lissner L, Sj&#246;str&#246;m    L. Body compartment and subcutaneous adipose tissue distribution- risk factor    patterns in obese subjects. Obes Res. 1995; 3: 9-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Body compartment and subcutaneous adipose tissue distribution- risk factor patterns in obese subjects</article-title>
          <source>Obes Res</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>9</fpage>
          <lpage>22</lpage>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sj&#246;str&#246;m</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>H&#229;kang&#229;rd</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lissner</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sj&#246;str&#246;m</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B51">
        <mixed-citation>51. Laakso M, Matilainen V, Kein&#228;nen-Kiukaanniemi    S. Association of neck circumference with insulin resistance-related factors.    Int J Obes Relat Metab Disord. 2002; 26 (6): 873-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association of neck circumference with insulin resistance-related factors</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>873</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Laakso</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matilainen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kein&#228;nen-Kiukaanniemi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B52">
        <mixed-citation>52. Ben-Noun L, Laor A. Relationship of neck    circumference to cardiovascular risk factors. Obes Res. 2003; 11 (2): 226-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship of neck circumference to cardiovascular risk factors</article-title>
          <source>Obes Res</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>226</fpage>
          <lpage>31</lpage>
          <issue>2</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ben-Noun</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Laor</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B53">
        <mixed-citation>53. McCarthy HD, Ashwell M. A study of central    fatness using waist-to-height ratios in UK children and adolescents over two    decades supports the simple message--'keep your waist circumference to less    than half your height'. Int J Obes. 2006; 30 (6): 988-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message--'keep your waist circumference to less than half your height'</article-title>
          <source>Int J Obes</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>988</fpage>
          <lpage>92</lpage>
          <issue>6</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McCarthy</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Ashwell</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B54">
        <mixed-citation>54. Parikh RM, Joshi SR, Menon PS, Shah NS. Index    of central obesity: a novel parameter. Med Hypotheses. 2007; 68 (6): 1272-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Index of central obesity: a novel parameter</article-title>
          <source>Med Hypotheses</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1272</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>68</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Parikh</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Menon</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>NS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B55">
        <mixed-citation>55. Ashwell M, Hsieh SD. Six reasons why the    waist-to-height ratio is a rapid and effective global indicator for health risks    of obesity and how its use could simplify the international public health message    on obesity. Int J Food Sci Nutr. 2005; 56 (5): 303-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity</article-title>
          <source>Int J Food Sci Nutr</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>303</fpage>
          <lpage>7</lpage>
          <issue>5</issue>
          <volume>56</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ashwell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B56">
        <mixed-citation>56. Hsieh SD, Muto T. The superiority of waist-to-height    ratio as an anthropometric index to evaluate clustering of coronary risk factors    among non-obese men and women. Prev Med. 2005; 40 (2): 216-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women</article-title>
          <source>Prev Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>216</fpage>
          <lpage>20</lpage>
          <issue>2</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hsieh</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Muto</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B57">
        <mixed-citation>57. Valdez R. A simple model-based index of abdominal    adiposity. J Clin Epidemiol. 1991; 44 (9): 955-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A simple model-based index of abdominal adiposity</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>955</fpage>
          <lpage>6</lpage>
          <issue>9</issue>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Valdez</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B58">
        <mixed-citation>58. Valdez R, Seidell JC, Ahn YI, Weiss KM. A    new index of abdominal adiposity as an indicator of risk for cardiovascular    disease: a cross-population study. Int J Obes Relat Metab Disord. 1993; 17 (2):    77-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A new index of abdominal adiposity as an indicator of risk for cardiovascular disease: a cross-population study</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>77</fpage>
          <lpage>82</lpage>
          <issue>2</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Valdez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Ahn</surname>
              <given-names>YI</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B59">
        <mixed-citation>59. Mantzoros CS, Evagelopoulou K, Georgiadis    EI, Katsilambros N. Conicity index as a predictor of blood pressure levels,    insulin and triglyceride concentrations of healthy premenopausal women. Horm    Metab Res. 1996; 28 (1): 32-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Conicity index as a predictor of blood pressure levels, insulin and triglyceride concentrations of healthy premenopausal women</article-title>
          <source>Horm Metab Res</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>32</fpage>
          <lpage>4</lpage>
          <issue>1</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mantzoros</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Evagelopoulou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Georgiadis</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Katsilambros</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B60">
        <mixed-citation>60. Monteiro JC. Obesidade: diagn&#243;stico,    m&#233;todos e fundamentos. In: Halpern A, Matos AFG, Suplicy HL, Mancini    MC, Zanella MT. Obesidade. S&#227;o Paulo: Lemos; 1998. p. 31.</mixed-citation>
        <element-citation publication-type="book">
          <source>Obesidade</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>31</fpage>
          <person-group person-group-type="author">
            <name>
              <surname>Monteiro</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Matos</surname>
              <given-names>AFG</given-names>
            </name>
            <name>
              <surname>Suplicy</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Mancini</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Zanella</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B61">
        <mixed-citation>61. Snijder MB, van Dam RM, Visser M, Seidell    JC. What aspects of body fat are particularly hazardous and how do we measure    them? Int J Epidemiol. 2006; 35 (1): 83-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>What aspects of body fat are particularly hazardous and how do we measure them</article-title>
          <source>Int J Epidemiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>83</fpage>
          <lpage>92</lpage>
          <issue>1</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Snijder</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>van Dam</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seidell</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B62">
        <mixed-citation>62. Farin HM, Abbasi F, Reaven GM. Body mass    index and waist circumference both contribute to differences in insulin-mediated    glucose disposal in nondiabetic adults. Am J Clin Nutr. 2006; 83 (1): 47-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults</article-title>
          <source>Am J Clin Nutr</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>47</fpage>
          <lpage>51</lpage>
          <issue>1</issue>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Farin</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Abbasi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Reaven</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B63">
        <mixed-citation>63. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres    C, Carmena R. Insulin resistance quantification by fasting insulin plasma values    and HOMA index in a non-diabetic population. Med Clin. 2001; 117 (14): 530-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population</article-title>
          <source>Med Clin</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>530</fpage>
          <lpage>3</lpage>
          <issue>14</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ascaso</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Real</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Priego</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Valdecabres</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carmena</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B64">
        <mixed-citation>64. Chang SA, Kim HS, Yoon KH, Ko SH, Kwon HS,    Kim SR, et al. Body mass index is the most important determining factor for    the degree of insulin resistance in non-obese type 2 diabetic patients in Korea.    Metabolism. 2004; 53 (2): 142-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea</article-title>
          <source>Metabolism</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>142</fpage>
          <lpage>6</lpage>
          <issue>2</issue>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B65">
        <mixed-citation>65. Stern SE, Williams K, Ferrannini E, DeFronzo    RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance    using routine clinical measurements. Diabetes. 2005; 54 (2): 333-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Identification of individuals with insulin resistance using routine clinical measurements</article-title>
          <source>Diabetes</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>333</fpage>
          <lpage>9</lpage>
          <issue>2</issue>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stern</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ferrannini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>DeFronzo</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Bogardus</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stern</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B66">
        <mixed-citation>66. Tarastchuk JCE, Guerios EE, Bueno RRL, Andrade    Pm, Nercolini PC, Ferraz JG, et al. Obesidade e interven&#231;&#227;o coronariana:    devemos continuar valorizando o &#237;ndice de Massa Corp&#243;rea? Arq    Bras Cardiol. 2008; 90 (5): 311-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesidade e interven&#231;&#227;o coronariana: devemos continuar valorizando o &#237;ndice de Massa Corp&#243;rea?</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>311</fpage>
          <lpage>6</lpage>
          <issue>5</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tarastchuk</surname>
              <given-names>JCE</given-names>
            </name>
            <name>
              <surname>Guerios</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Bueno</surname>
              <given-names>RRL</given-names>
            </name>
            <name>
              <surname>Andrade Pm</surname>
            </name>
            <name>
              <surname>Nercolini</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Ferraz</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Update</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Anthropometric indicators of insulin resistance</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>Some studies have analyzed the efficacy of anthropometric indicators in predicting insulin resistance (IR), for they are more economic and accessible. In this study, the objective was to discuss the measures and anthropometric indices that have been associated with IR. A bibliographic review was done, based on Scielo, Science Direct and Pubmed. Among these studies, waist and sagittal abdominal diameter presented better predictive capacity for IR, with more consistent results. The waist-to-thigh, waist-to-size, neck-to-thigh ratios, the conicity and the sagittal index have showed positive results; nevertheless, more studies are necessary to consolidate them as predictors to IR. The obtained results, with the use of body mass index and of the waist-to-hip ratio, were inconsistent. In the Brazilian population, the realization of studies evaluating the performance of these indicators in predicting IR is suggested, since the results of the studies conducted in other populations are not always applicable to ours, due to ethnical differences resulting from the great miscegenation in the country.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Insulin resistance</kwd>
        <kwd>anthropometry</kwd>
        <kwd>obesity</kwd>
        <kwd>intra-abdominal fat</kwd>
        <kwd>abdominal circumference</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>CLINICAL UPDATE</bold>
      </p>
      <p><undefined id="tx-body2"/>Anthropometric indicators of insulin resistance</p>
      <p>
        <bold>Ana Carolina Vasques<sup>I</sup>; Lina Rosado<sup>I</sup>; Gilberto Rosado<sup>I</sup>; Rita de Cassia Ribeiro<sup>I</sup>; Sylvia Franceschini<sup>I</sup>; Bruno Geloneze<sup>II</sup></bold>
      </p>
      <p><sup>I</sup>Universidade Federal de Vi&#231;osa (UFV), Vi&#231;osa, MG</p>
      <p><sup>II</sup>Universidade Estadual de Campinas (UNICAMP), Campinas, SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p>Some studies have analyzed the efficacy of anthropometric indicators in predicting insulin resistance (IR), for they are more economic and accessible. In this study, the objective was to discuss the measures and anthropometric indices that have been associated with IR. A bibliographic review was done, based on Scielo, Science Direct and Pubmed. Among these studies, waist and sagittal abdominal diameter presented better predictive capacity for IR, with more consistent results. The waist-to-thigh, waist-to-size, neck-to-thigh ratios, the conicity and the sagittal index have showed positive results; nevertheless, more studies are necessary to consolidate them as predictors to IR. The obtained results, with the use of body mass index and of the waist-to-hip ratio, were inconsistent. In the Brazilian population, the realization of studies evaluating the performance of these indicators in predicting IR is suggested, since the results of the studies conducted in other populations are not always applicable to ours, due to ethnical differences resulting from the great miscegenation in the country.</p>
      <p><bold>Key words:</bold> Insulin resistance; anthropometry; obesity; intra-abdominal fat; abdominal circumference.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Insulin resistance (IR) syndrome is one of the main risk factors for cardiovascular diseases, presenting high morbimortality and socioeconomic expenses. The IR, which is considered a link between the other physiological changes that compound the complex state of this syndrome, is associated with visceral obesity; arterial hypertension; intolerance to glucose and to type 2 diabetes; dyslipidaemia; hyperuricemia, and other metabolic changes<sup>1-,3</sup>.</p>
      <p>The evaluation of the IR has received considerable attention in the last few years. In Brazil, the determination of IR has not been in the routine medical exams yet, and is not available in most of the health services. The laboratorial methods for the determination of IR are expensive and with standardization deficiencies for its execution, limiting the comparison between different laboratories results' and its application in clinical practice<sup>4</sup>.</p>
      <p>Studies have correlated the isolated anthropometric measures and the anthropometric indexes with IR<sup>5-9</sup>. The anthropometric indicators arise as an alternative for IR's evaluation with lower cost and higher easiness of application in epidemiological studies and in health basic attention services. Because of the importance of this theme, the objective was to discuss about the main measures and the anthropometric indexes that have been associated with IR.</p>
      <p>
        <bold>Methodology</bold>
      </p>
      <p>A bibliographic review was performed on available periodics in scientific bases, such as Scielo, Science Direct and Pubmed. The keywords used for the search of articles were: insulin resistance; anthropometry; body mass index; waist circumference; sagittal abdominal diameter; waist-hip ratio; conicity index; waist-thigh ratio; neck circumference; and waist-stature ratio. Published articles were selected between 1990 and 2007, besides of the incorporation of classic previously published papers concerning the theme. Most of the studies included in this review were transversal. Some case-control and cohorts works were also discussed. Articles characterized by scientific rigidity, concerning the sample's size and statistical analysis appropriate to the objectives of the study.</p>
      <p>
        <bold>Insulin resistance</bold>
      </p>
      <p>
        <bold>Laboratorial determination</bold>
      </p>
      <p>IR can be determined directly from the management of a predetermined quantity of exogenous insulin, or indirectly, based on the concentrations of endogenous insulin<sup>10</sup>.</p>
      <p>The euglycemic hyperinsulinemic clamp is an example of a direct technique that allows the determination of a metabolized insulin quantity, by the peripheric tissues during the stimulation with insulin. Although nowadays it is the golden standard technique for evaluating the IR <italic>in vivo</italic>, it is costly, slowly and of high complexity, being feasible its application in population studies, and especially in clinical practice<sup>11</sup>.</p>
      <p>The Homeostasis Model Assessment (HOMA) index represents one of the alternatives to the clamp technique for evaluating IR. It is a mathematic model that predicts IR's level from the basal glycaemia and insulinaemia, in homeostasis conditions, being represented by the equation<sup>12</sup>:</p>
      <p>HOMA = [Fasting insulinaemia (mU/l) x Fasting glycaemia (mmol/l)] / 22.5</p>
      <p>The HOMA has been widely used, specially in population studies, due to its easiness of application and to the strong and significant correlation with the direct techniques of evaluation of IR, observed in validations papers<sup>13,14</sup>. Nevertheless, for diagnosis or individual follow-up, its use still requires caution in questions related to the blood sample and to the defective standardization of assays to be used by the laboratories in the insulin dosage<sup>4</sup>, pointing the need of more accessible and viable methods for clinical practice.</p>
      <p>
        <bold>Anthropometric indicators</bold>
      </p>
      <p>The development of computed tomography and of magnetic resonance image represented an important advance in the research of a body composition in human beings, because they allow accurate and precise measurement of the visceral and subcutaneous fat, located in the abdominal region. Ultrasonography and dual energy x-ray absorptiometry (DEXA) can also be used to evaluate abdominal fat, although the latter does not distinction between subcutaneous and visceral fat<sup>15,16</sup>. However, these techniques are costly and many times unavailable.</p>
      <p>The anthropometric measures are indicatives of the nutritional state, present low cost, inocuity, simplicity in its execution and have acted as obesity indicators<sup>17</sup>. The correlations between the anthropometric indicators and IR have been widely studied, detaching them as non-invasive indicators for the evaluation of risk of IR, both in the epidemiologic search as in clinical practice.</p>
      <p>The anthropometric indexes can be classified according to the evaluated obesity type<sup>17</sup>. Amongst the central obesity indicators there are: waist perimeter (WP), the sagittal abdominal diameter (SAD), conicity index (COI) and the waist-stature ratio. The body fat distribution has been evaluated by the waist-hip ratio, the sagittal index (SI), the waist-thigh ratio and the neck-thigh ratio. For the generalized obesity, the body mass index (BMI) has been the most used. <xref ref-type="table" rid="en_a25tab01-body2">Table 1</xref> summarizes the main discussed studies in this review, which evaluated anthropometric indicators as predictors of IR. </p>
      <p content-type="asset">
        <table-wrap id="en_a25tab01-body2">
          <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gt01-en.jpg"/></table-wrap>
      </p>
      <p>Although the obesity indicators are related to IR, it should be noteworthy that IR is not a metabolic alteration exclusive of obesity and diabetes <italic>mellitus</italic> type 2 porters, as it happens in patients with of lipoatrophic diabetes, in which there is a genetic defect of insulin's action in skinny subjects. In the same way, some patients with normal BMI can present IR because of the visceral fat accumulation, composing a phenotype known as Metabolically Obese Normal Weight (MONW)<sup>18</sup>.</p>
      <p>
        <bold>Waist perimeter</bold>
      </p>
      <p>The practicality in the application of WP, its association with cardiovascular risk factors and the strong correlation with the visceral fat area measured by computed tomography, from the order 0.73 to 0.81<sup>19,20</sup>, are characteristics that have made it the most used indicator of abdominal adiposity. Besides that, the evaluation of the WP is in the proposals of the European Group for the Study of Insulin Resistance<sup>21</sup>, the International Diabetes Federation<sup>22</sup> and of the National Cholesterol Education Program (NCEP-ATP III)<sup>23</sup>, for the diagnosis of the IR syndrome.</p>
      <p>In 1995, Han et al<sup>24</sup> have showed that the WP values above 80 and 88 cm for women, and above 94 and 102 cm for men, indicated increased and very increased risk, respectively, of metabolic complications. Later, the NCEP-ATP III<sup>23 </sup>adopted the 88 and 102 cm values for the diagnosis of central obesity in men and women, respectively, these which have been used especially in Brazil. Populations differ between each other, according to the risk level presented for a WP datum, being impossible to determine cut points globally applicable. The International Diabetes Federation recommends the use of different cut points, according to ethnicity (<xref ref-type="table" rid="tab2-body2">Table 2</xref>)<sup>22</sup>.</p>
      <table-wrap id="tab2-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gt02-en.jpg"/></table-wrap>
      <p>Although WP is largely diffusive, there are different descriptions for assessing and, consequently, consensus absence between researchers and published protocols, which can create conflicts at the time the measure is taken. Between the most used, there is the medium point between the iliac crest and the last rib, recommended by the World Health Organization (WHO)<sup>25</sup>; the smallest waist between the thorax and the hip, recommended by the Anthropometric Standardization Reference Manual<sup>26</sup>; the level immediately above the iliac crests, as recommended by the National Institute of Health<sup>27</sup>; and the umbilical level<sup>8</sup> (<xref ref-type="fig" rid="fig1-body2">Figure 1</xref>).</p>
      <fig id="fig1-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf01-en.jpg"/></fig>
      <p>Ross et al<sup>28</sup> have checked that the protocol used for measurement of the WP does not have essential influence in its association with cardiovascular diseases and type 2 diabetes. In Wang et al study<sup>29</sup>, although no correlations between WP and morbidity risks have been carried out, the authors suggest that the comparisons among different papers are only valid when the same anatomic place is used for checking. These researchers have made comparisons between WP measures, taken in four places (smallest waist; immediately below the last rib; medium point between the iliac crest and the last rib and right above the iliac crest) in 111 subjects. In both sexes, differences were found, showing that the four places are not identical.</p>
      <p>Several studies have evaluated the relation between WP and IR. In a study carried out with 8,400 subjects, WP associated positively and independently with type 2 diabetes<sup>30</sup>. In Weidner et al work<sup>31</sup>, WP was the first anthropometric variable in the multivariated regression analysis, contributing with approximately 37% for a variation in insulin's sensibility. In a case-control study carried out with 300 Indians, WP was identified as the precisest predictor of risk for type 2 diabetes and its biochemical indicators<sup>32</sup>.</p>
      <p>In a paper carried out with Caucasians, WP was identified as a strong predictor of IR, especially in men. The best cut points of WP were evaluated for predicting IR, being 97.5 cm and 106.5 cm the values found for women and men, respectively. Yet, when the values of 88 cm for women and 102 cm, for men are compared, recommended by the NCEP-ATP III<sup>23</sup>, the new cut points did not seem to be superior in identifying subjects with IR<sup>33</sup>.</p>
      <p>In Pouliot et al study<sup>19</sup>, the increment in WP measures was consistent to the increase of glycaemia and insulinaemia of fasting and post-prandial, especially in women, suggesting that these measures are cardiovascular risk indicators. The authors suggest that the WP values above 100 cm are related to the greatest chance of development of metabolic complications.</p>
      <p>
        <bold>Sagittal abdominal diameter</bold>
      </p>
      <p>The SAD represents an abdominal height, comprising the distance between the back and the abdomen<sup>34</sup>. It can be checked with the person standing<sup>35</sup> or in the supine position (<xref ref-type="fig" rid="fig2-body2">Figure 2</xref>), this last position is the most used<sup>7,35,36</sup>.</p>
      <fig id="fig2-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf02-en.jpg"/></fig>
      <p>In the supine position, the visceral adipose tissue tends to raise the abdominal wall in the sagittal direction, and the abdominal adipose subcutaneous anterior or lateral tissue compresses the abdomen or tends to descend to both sides due to the gravity strength. Thus, it is expected that the assessed SAD in the supine position reflects specially the volume of the visceral adipose tissue<sup>37</sup>.</p>
      <p>The anatomical place used for the assessing differs between the studies, being used the smallest waist between the thorax and hip<sup>38</sup>; the highest abdominal height<sup>39</sup>; the umbilical scar<sup>40</sup>; the medium point between the last rib and the iliac crest<sup>36</sup>; and the medium point between the iliac crests<sup>41</sup>. The latter coincides with the localization of the lombar vertebral L4 and L5, the most used place by the images techniques for quantification of the visceral adipose tissue area and, maybe, the most indicated for assessing of SAD<sup>42</sup>.</p>
      <p>The measurement of SAD can be done by anthropometry with the help of one abdominal <italic>caliper</italic>, or by image techniques, like the computed tomography or magnetic resonance image, since lots of studies have showed strong correlation between both techniques<sup>36,43</sup>.</p>
      <p>SAD has been recommended as an indicator of deposition of visceral abdominal fat and of cardiovascular risk evaluation<sup>44,45</sup>. Recently, cut points were proposed for SAD evaluation in Brazilians, based on a quantity of increased visceral abdominal fat, which corresponds to a superior value to 100 cm<sup>2</sup>. For the female and male sex, the cut points were 19.3 and 20.5 cm, respectively<sup>20</sup>.</p>
      <p>SAD has showed strong association with glucose intolerance and with IR. Gustat et al<sup>38 </sup>have identified SAD as an independent predictor of glycaemia and insulinaemia, pointing this anthropometric measure as an excellent marker of IR.</p>
      <p>In Ris&#233;rus et al study<sup>7</sup>, SAD presented stronger correlation with IR, glycaemia, insulinaemia, C-peptide and hyperproinsulinemia than the BMI, WP and waist-hip ratio. In the analysis of a univariated multiple regression, including all the anthropometric variables, SAD was the only independent predictor of IR. The study of Petersson et al<sup>44</sup>, which was done with Swedish women, the SAD was also the best clinical marker of IR among the others, including WP, the waist-hip ratio and the BMI. In Pouliot et al study<sup>19</sup>, besides WP, the SAD increment was also consistent to the increase on the fasting and post-prandial glycaemia and insulinaemia. In this paper, SAD values above 25 cm were associated with the highest development probability of metabolic disturbances with atherogenic potential.</p>
      <p>
        <bold>Waist-hip ratio</bold>
      </p>
      <p>The waist-hip ratio is the index of regional distribution of body fat most used in the epidemiological research. It is based on the ratio between the WP values and the hip's perimeter (HP). The anatomical place most used for the assessing of HP is in the height of the greatest trochanter, recommended by the WHO<sup>25</sup>. The waist and hip's perimeter reflect different aspects of the body composition, and possess independent and opposite effects in determining the risk of cardiovascular diseases and its risk factors. Narrow waists and large hips are associated with protection against cardiovascular diseases. This ratio has been explained by the following theory: narrow hips reflect a reduced quantity of muscular mass, which contributes for the minor insulin activity in the skeptical musculature and for the minor concentration and activity of lipoproteic lipase in the muscles, with concomitant reduction in the capture and use of fatty acid by the muscular cells. In contrast, large hips present higher concentration of lipoproteic lipase due to the biggest quantity of muscular tissue. Besides that, there is lower turnover of fatty acids in the gluteofemoral adipose tissue in relation to the visceral adipose tissue, which aids insulin sensibility. However, the independent effects of each one of the perimeters can be confused in the waist-hip ratio, so the interpretation of its values is much more complex<sup>46</sup>.</p>
      <p>Waist-hip ratio is partially independent of total adiposity. Skinny and obese individuals can present the same waist-hip ratio value, even though there is a substantial interindividual variation in the total fat mass and in the visceral and subcutaneous abdominal adipose tissue<sup>19</sup>. Moreover, waist-hip ratio can be unaltered even when changes in the body adiposity happens, due to similar alterations in both perimeters that not alter the final relation. Thus, it is important to be cautious when using waist-hip ratio as an indicator of visceral fat accumulation, being this an inappropriate relation to assess changes in visceral fat quantity during the loss or gain of weight<sup>47</sup>.</p>
      <p>In Pouliot et al study<sup>19</sup>, although the waist-hip ratio has not been the best predictor of disturbances in the glucose and insulin metabolism, authors have suggested that the waist-hip ratio values above 0.8 for women, and 1.0 for men, would be associated with these metabolic alterations.</p>
      <p>In Riserus et al<sup>7</sup>, Mamtani et al<sup>32</sup> and Petterson et al<sup>44</sup> studies, waist-hip ratio has presented as a less useful instrument to predict IR, compared to the other anthropometric measures studies.</p>
      <p>
        <bold>Sagittal index</bold>
      </p>
      <p>Although less known and used between researchers and health professionals, the SI was proposed as an alternative to waist-hip ratio for estimation of the body fat distribution and for the prediction of morbidities. The SI is represented by the reason between SAD (cm) and the thigh medium perimeter (cm). In order to use it, SAD and the thigh medium perimeter, assessed in the medium point between the inguinal fold and the proximal border of patella (<xref ref-type="fig" rid="fig3-body2">Figure 3</xref>), they would be measured with better representivity of the tissues in interest, compared to the waist and hip's perimeter, respectively<sup>47</sup>.</p>
      <fig id="fig3-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf03-en.jpg"/></fig>
      <p>The measure of the thigh's medium perimeter comprises the skeptical musculature, the femur and the subcutaneous and intramuscular adipose tissue. These three tissues are analogue to the ones that surround the intra-abdominal content, composed of the skeptical musculature, the vertebras and the subcutaneous adipose tissue. As the visceral adipose tissue is the abdominal compartment of interest, the thigh's medium perimeter represents a measure of comparison with the abdominal measures<sup>47</sup>. As an advantage, in contrary to the hip's perimeter, the thigh's medium perimeter is not affected by the variations in the pelvic architecture. Besides, the thigh's medium perimeter and the SAD are measured with increased precision<sup>34</sup>. The thigh's medium point is the most used to represent the central portion of the muscle, which reflects the muscular mass and the practice of physical exercises. Individuals with increased content of muscular mass and subcutaneous adipose tissue in the thigh can present a bigger answer to the signalization of insulin and low cardiovascular risk<sup>47</sup>. </p>
      <p>In a study carried out in Brazil, the SI presented lesser correlation with the visceral adipose tissue than SAD; however, there was no correlation of the SI with the area of subcutaneous abdominal fat<sup>20</sup>. In the study of Kahn et al<sup>48</sup>, among the traditional anthropometric measures, like BMI and the waist-hip ratio, the SI was a better predictor of sudden coronary death in men. Smith et al<sup>49</sup> evaluated the strength of the association of six anthropometric parameters with known factors of cardiovascular risk in men of different ethnicities. SI was the one which presented the highest Odds Ratio for the cardiovascular disease. Although these papers have presented good results for the SI, studies evaluating its utility in predicting IR and other factors of cardiovascular risk are still scarce.</p>
      <p>
        <bold>Waist-thigh ratio</bold>
      </p>
      <p>Waist-thigh ratio presents a fundamental similar to the one applied in the SI, regarding the use advantages' of the thigh's perimeter in prejudice to hip's perimeter, calculated from the ratio between WP values' (cm) and the thigh's medium perimeter (cm). </p>
      <p>In Chuang et al study<sup>8</sup> with Orientals (n = 6,007), between the 32 evaluated measures by laser scanning in three dimensions, the WP, representing the trunk, and the thigh's medium perimeter, representing the inferior part of the body, were the best indicators of type 2 diabetes. By the comparison between the waist-thigh ratio and the known anthropometric indicators, among them there is the BMI, the waist-hip ratio and thigh's perimeter, the authors have identified stronger correlations for the waist-thigh ratio. Kahn et al<sup>48</sup> have showed in their study that, the waist-thigh ratio have had great performance for evaluating cardiovascular risk disease, parallel to SI.</p>
      <p>
        <bold>Neck-thigh ratio</bold>
      </p>
      <p>Neck-thigh ratio comprises the reason between neck's perimeter (cm), assessed in the medium point of the neck's height (<xref ref-type="fig" rid="fig4-body2">Figure 4</xref>), and the thigh's medium perimeter (cm), those which have been used as distribution indexes of subcutaneous adipose tissue of superior and inferior body parts, respectively. Following the tricompartimental body composition (visceral and subcutaneous adipose tissue), after adjustment for scarce mass and visceral adipose tissue, Sj&#246;str&#246;m et al identified positive correlation between neck's perimeter and cardiovascular risk factors related to IR, while the thigh's perimeter showed inverse correlation<sup>50</sup>.</p>
      <fig id="fig4-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf04-en.jpg"/></fig>
      <p>Laakso et al<sup>51</sup>, in a study carried out with 541 adults distributed according to quintiles of the neck's perimeter, identified major frequencies of hyperglycemia and hyperinsulinemia in the superior quintiles of measure, suggesting the use of neck's perimeter, in population screenings as a marker of risk individuals for IR. Ben-Noun and Laor<sup>52</sup> also found significant correlation between the neck's perimeter, with several cardiovascular risk factors related to IR.</p>
      <p>Although papers evaluating neck-thigh ratio are rare, it is noteworthy that the neck's perimeter represents a quick and easy measure to happen, yonder not presenting variations in its extent throughout the day.</p>
      <p>
        <bold>Waist-stature ratio</bold>
      </p>
      <p>Waist-stature ratio is the reason between WP (cm) and the stature (cm). It is assumed that, for a determined stature, there is an acceptable fat degree stored in the body's superior part. Even so the precise effect of stature on the WP is quantitatively unknown, some authors assert that stature has an influence on the magnitude of WP through growing and adult life<sup>53,54</sup>.</p>
      <p>Studies show that, although waist-stature ratio has good correlation with visceral fat, it should be the anthropometric indicator used for the prediction of metabolic risks associated with obesity<sup>17,54</sup>. The most used argument is that WP<sup>54</sup> and the BMI<sup>55</sup> need several cut points, depending on the ethnicity and gender<sup>22,25</sup>, which would supposedly difficult its use. According to these authors, WP value's maintenance below the value corresponding to stature's measure, would represent a simple and effective message for all the population, in a way that it can helps to prevent IR syndrome<sup>54,55</sup>. A study conducted with Iranian men showed that the waist-stature ratio presented better performance in predicting type 2 diabetes, compared to BMI<sup>9</sup>.</p>
      <p>Amongst waist-stature ratio, there would be the relation with cardiovascular risk factors, including fasting insulinaemia<sup>17</sup>; the increased sensibility in detecting precociously risk factors, when compared to BMI; and the simplicity of execution united to easiness of one cut point for individual's classification, in which the 0.5-value, determined based on the great balance between sensibility and specificity, could be universally used<sup>55,56</sup>. Ho et al<sup>17</sup> study found 0.48 value as the best cut point for the prediction of hyperinsulinemia in Chinese men.</p>
      <p>In spite of waist-stature ratio uses stature and allows its application in several ethnicities, it can be questioned if the distinguished standard of body fat distribution, among men and women, would difficult the use of only one cut point for both sexes. However, men are taller and present higher measures for WP in relation to women. Thus, waist-stature ratio means are similar to both sexes due to the adjustment for the stature<sup>54</sup>.</p>
      <p>
        <bold>Conicity index</bold>
      </p>
      <p>COI represents an abdominal obesity indicator and was proposed by Valdez<sup>57</sup>. This index considers that, individuals with less accumulation of fat in the central part would have a body form similar to a cylinder, while those with bigger accumulation would assimilate to a double cone, with this as a common basis. </p>
      <p>COI equation's regards WP measures, body weight, stature and 0.109 constant, which represents the conversion of volume and mass units' for lengths units<sup>58</sup>:</p>
      <p>
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-e01-en.jpg"/></p>
      <p>COI is a simple interpretation, once the denominator is the cylinder produced by the evaluated weight and stature. Hence, a COI equals to 1.20 means that the WP is 1.20 higher than the cylinder perimeter created from the by the evaluated weight and stature, reflecting the adiposity excess in the abdominal region. COI does not have a measure unit and its theoretical range is of 1.00 (perfect cylinder) to 1.73 (double cone)<sup>58</sup>. </p>
      <p>In its advantages, there is the fact of including in its stature, a WP adjustment for weight and stature, allowing direct comparisons of abdominal adiposity among the subjects our populations. Farther on, COI has a weak correlation with stature that is desirable for any indicator of obesity<sup>57,58</sup>.</p>
      <p>In a multicenter study, with 2,240 adults, insulinaemia has presented correlation standards consistent with COI<sup>58</sup>. Pitanga and Lessa<sup>6</sup> conducted a work in Brazil, with 2,297 people, and identified COI as a glycaemia discriminator and of cardiovascular risk. These authors made a table to make easy the use of COI, in which, from weight and stature values, it has already calculated the index denominator. Thus, conicity of any waist value, for a given weight and stature, can be promptly analyzed, enabling to foretell the risks of diseases associated with abdominal adiposity, like IR. </p>
      <p>In contrast, in Mantzoros et al study<sup>59</sup>, carried out in Greece, with 280 healthy women of 18 to 24 years old, COI presented a very weak correlation (r = 0.13, p = 0.03) with fasting insulinaemia. Mamtani and Kuljarni<sup>32</sup>, comparing the performance of various anthropometric parameters related to central obesity, have checked that COI was the one which presented less predictive accuracy for the central obesity measures'. In the same study, COI did not show correlation with fasting and post-prandial glycaemia. So, it is observed the need of more investigations about this index, to determine its viability in the risk prediction of IR.</p>
      <p>
        <bold>Body mass index</bold>
      </p>
      <p>The BMI is weight in kilograms divided by height in meters squared<sup>60</sup>. It represents the most known and used indicator of nutritional status to evaluate adults and old-aged, due to its easiness of application and low cost. Due to its incapacity of evaluating the distribution of body fat, it characterizes as an indicator of generalized adiposity. Changes in the BMI do not reflect the anatomical place in which the subject can have lost or loosen weight<sup>61</sup>. Generally, BMI shows weaker correlations with visceral fat than the WP and SAD<sup>20,43</sup>.</p>
      <p>The papers that evaluated the capacity of BMI in predicting IR are presenting conflicting results. In the study of Farin et al<sup>62</sup>, there were no differences in the magnitude of correlations between BMI with IR in Caucasians. From the regression analysis, both indicators of generalized and central adiposity showed the same capacity of identifying subjects with IR. In the paper of Ascaso et al<sup>63</sup>, conducted with Spanish people, both WP or the BMI correlated with IR. In the logistic regression analysis, only the BMI remained in the model as an Odds Ratio of 2.6, while WP lost statistical significance. Chang et al<sup>64</sup> identified the BMI as the most important determinant of IR in Orientals. However, the correlations among the BMI and IR were weak, and this was the only anthropometric indicator used in the study. Ybarra et al<sup>33</sup> affirmed that the best cut points of BMI to predict IR, are values from 29.5 kg/m&#178;, for women, and 30.5 kg/m&#178;, for men. Such cut points assimilate to 30 kg/m&#178;, proposed by the WHO<sup>25</sup>, for obesity's classification. Nevertheless, as this paper was conducted with Spanish people, it can not be generalized to the other ethnicities. Stern et al<sup>65</sup> evaluated 2,321 subjects of several ethnicities and identified, as cut points for predicting IR, BMI values' &gt; 28.7 kg/m<sup>2</sup>.</p>
      <p>Even though the mentioned papers have indicated positive results for the BMI in the prediction of IR, several studies which evaluated central adiposity measures<sup>7,17,44,54,66</sup> or of body fat distribution<sup>8,17</sup>, showed their superiority related to the BMI, probably due to the association between IR and the accumulation of visceral adipose tissue that is better represented by these measures. Moreover, due to the BMI's incapacity of distinguishing thin or fat body mass, its use for the prediction of IR can overestimate the risk in individuals with increased quantity of muscular mass, like athletes, and overestimate the risk in old-aged whose muscular mass, generally, is reduced and there is an increased accumulation of visceral adipose tissue<sup>17</sup>.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>The scarcity of studies comparing several anthropometric indicators in only one paper difficults the conclusion of which one is the best indicator for predicting IR. Yet, WP and SAD seem to present better predictive capacity for IR, once the results were more consistent among the papers. Waist-thigh ratio, the COI, the SI, neck-thigh ratio and waist-height ratio have demonstrated positive results; however, more studies are necessary to solidify them as IR indicators. The results of the BMI and waist-hip ratio were more inconsistent. Although it is extremely useful, from a clinical point of view, to identify adiposity anthropometric indicators that present the best capacity of identifying subjects with IR, it is important to consider that, from them, the risk will always be evaluated, for they are alternative methods and do not explain IR as a whole. Important variables which have an influence in the modulation of insulin's action, as the life style and the genetic factors, must be considered. </p>
      <p>
        <bold>Acknowledgements</bold>
      </p>
      <p>Support from <italic>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Minas Gerais</italic> (Fapemig) and the National Counsel of Technological and Scientific Development (CNPq).</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by CNPq and FAPEMIG.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Ana Carolina Junqueira Vasques, from <italic>Universidade Federal de Vi&#231;osa</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Indicadores antropom&#233;tricos de resistencia a la insulina</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>Algunos estudios han analizado la eficiencia de indicadores antropom&#233;tricos para predecir resistencia a la insulina (RI), por ser m&#225;s econ&#243;micos y accesibles. En este estudio, se busc&#243; discutir sobre las medidas e &#237;ndices antropom&#233;tricos que han sido asociados a la RI. Se realiz&#243; un levantamiento bibliogr&#225;fico en las bases Scielo, Science Direct y Pubmed. Entre los estudios analizados, per&#237;metro de la cintura y di&#225;metro abdominal sagital presentaron mejor capacidad predictiva para RI, con resultados m&#225;s consistentes. Las relaciones cintura/muslo, cintura/estatura, cuello/muslo, el &#237;ndice de conicidad y el &#237;ndice sagital demostraron resultados positivos, con todo son necesarios m&#225;s estudios para consolidarlos como predictores de RI. Los resultados obtenidos con el uso del &#237;ndice de masa corporal y de la relaci&#243;n cintura/cadera fueron m&#225;s inconsistentes. Se sugiere la realizaci&#243;n de estudios evaluando el desempe&#241;o de esos indicadores para predecir RI en la poblaci&#243;n brasile&#241;a, pues resultados de estudios hechos con otras poblaciones muchas veces no son aplicables a la nuestra, debido a las diferencias &#233;tnicas resultantes de la gran mezcla de razas en el Pa&#237;s.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Resistencia a la insulina</kwd>
        <kwd>antropometr&#237;a</kwd>
        <kwd>obesidad</kwd>
        <kwd>grasa intra-abdominal</kwd>
        <kwd>circunferencia abdominal</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ACTUALIZACI&#211;N CL&#205;NICA</bold>
      </p>
      <p>
        <bold>Indicadores antropom&#233;tricos de resistencia a la insulina</bold>
      </p>
      <p>
        <bold>Ana Carolina Vasques<sup>I</sup>; Lina Rosado<sup>I</sup>; Gilberto Rosado<sup>I</sup>; Rita de Cassia Ribeiro<sup>I</sup>; Sylvia Franceschini<sup>I</sup>; Bruno Geloneze<sup>II</sup></bold>
      </p>
      <p><sup>I</sup>Universidade Federal de Vi&#231;osa (UFV), Vi&#231;osa, MG</p>
      <p><sup>II</sup>Universidade Estadual de Campinas (UNICAMP), Campinas, SP - Brasil</p>
      <p>
        <xref ref-type="corresp" rid="add1-body3">Correspondencia</xref>
      </p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p>Algunos estudios han analizado la eficiencia de indicadores antropom&#233;tricos para predecir resistencia a la insulina (RI), por ser m&#225;s econ&#243;micos y accesibles. En este estudio, se busc&#243; discutir sobre las medidas e &#237;ndices antropom&#233;tricos que han sido asociados a la RI. Se realiz&#243; un levantamiento bibliogr&#225;fico en las bases <italic>Scielo, Science Direct</italic> y <italic>Pubmed</italic>. Entre los estudios analizados, per&#237;metro de la cintura y di&#225;metro abdominal sagital presentaron mejor capacidad predictiva para RI, con resultados m&#225;s consistentes. Las relaciones cintura/muslo, cintura/estatura, cuello/muslo, el &#237;ndice de conicidad y el &#237;ndice sagital demostraron resultados positivos, con todo son necesarios m&#225;s estudios para consolidarlos como predictores de RI. Los resultados obtenidos con el uso del &#237;ndice de masa corporal y de la relaci&#243;n cintura/cadera fueron m&#225;s inconsistentes. Se sugiere la realizaci&#243;n de estudios evaluando el desempe&#241;o de esos indicadores para predecir RI en la poblaci&#243;n brasile&#241;a, pues resultados de estudios hechos con otras poblaciones muchas veces no son aplicables a la nuestra, debido a las diferencias &#233;tnicas resultantes de la gran mezcla de razas en el Pa&#237;s. </p>
      <p><bold>Palabras clave:</bold> Resistencia a la insulina, antropometr&#237;a, obesidad, grasa intra-abdominal, circunferencia abdominal.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>El s&#237;ndrome de resistencia a la insulina (RI) es uno de los principales factores de riesgo para las enfermedades cardiovasculares, presentando elevada morbimortalidad y elevados costos socioecon&#243;micos. La RI, considerada el nexo entre las dem&#225;s alteraciones fisiol&#243;gicas que componen el complejo cuadro de ese s&#237;ndrome, est&#225; asociada a la obesidad visceral, a la hipertensi&#243;n arterial, a la intolerancia a la glucosa, a la diabetes tipo 2, a las dislipidemias, a la hiperuricemia, entre otras alteraciones metab&#243;licas<sup>1-3</sup>.</p>
      <p>La evaluaci&#243;n de la RI ha recibido considerable atenci&#243;n en los &#250;ltimos a&#241;os. En Brasil, la determinaci&#243;n de la RI todav&#237;a no hace parte de los ex&#225;menes m&#233;dicos de rutina y no est&#225; disponible en la mayor&#237;a de los servicios de salud. Los m&#233;todos de laboratorio para la determinaci&#243;n de la RI son dispendiosos y con deficiencias de estandarizaci&#243;n para su ejecuci&#243;n, limitando la comparaci&#243;n entre los resultados de diferentes laboratorios y su aplicaci&#243;n en la pr&#225;ctica cl&#237;nica<sup>4</sup>.</p>
      <p>Estudios han correlacionado las medidas antropom&#233;tricas aisladas y los &#237;ndices antropom&#233;tricos con la RI<sup>5-9</sup>. Los indicadores antropom&#233;tricos surgen como una alternativa para la evaluaci&#243;n de la RI con menor costo y mayor facilidad de aplicaci&#243;n en los estudios epidemiol&#243;gicos y en los servicios de atenci&#243;n b&#225;sica a la salud. En virtud de la importancia de ese tema, se procur&#243; discutir sobre las principales medidas e &#237;ndices antropom&#233;tricos que han sido asociados a la RI.</p>
      <p>
        <bold>Metodolog&#237;a</bold>
      </p>
      <p>Se realiz&#243; un levantamiento bibliogr&#225;fico con consulta a peri&#243;dicos disponibles en las bases cient&#237;ficas <italic>Scielo</italic>, <italic>Science Direct</italic> y <italic>Pubmed</italic>. Los descriptores utilizados para la b&#250;squeda de los art&#237;culos fueron: resistencia a la insulina (<italic>insulin resistance</italic>); antropometr&#237;a (<italic>anthropometry</italic>); &#237;ndice de masa corporal (<italic>body mass index</italic>); circunferencia de la cintura (<italic>waist circumference</italic>); di&#225;metro abdominal sagital (<italic>sagittal abdominal diameter</italic>); relaci&#243;n cintura-cadera (<italic>waist-hip ratio</italic>); &#237;ndice de conicidad (<italic>conicity index</italic>); relaci&#243;n cintura-muslo (<italic>waist-thigh ratio</italic>); circunferencia del cuello (<italic>neck circumference</italic>); y relaci&#243;n cintura-estatura (<italic>waist-stature ratio</italic>). Fueron seleccionados art&#237;culos publicados entre 1990 y 2007, adem&#225;s de la incorporaci&#243;n de trabajos cl&#225;sicos referentes al tema publicados anteriormente. La mayor&#237;a de los estudios incluidos en esta revisi&#243;n fue transversal. Tambi&#233;n fueron discutidos algunos trabajos del tipo caso-control y algunas cohortes. Fueron incluidos art&#237;culos caracterizados por rigor cient&#237;fico no tocante al tama&#241;o de la muestra y an&#225;lisis estad&#237;stica adecuados a los objetivos del estudio.</p>
      <p>
        <bold>Resistencia a la insulina</bold>
      </p>
      <p>
        <bold>Determinaci&#243;n de laboratorio</bold>
      </p>
      <p>La RI puede ser determinada de forma directa, a partir de la administraci&#243;n de cantidad predeterminada de insulina ex&#243;gena, o de forma indirecta, bas&#225;ndose en las concentraciones de insulina end&#243;gena<sup>10</sup>.</p>
      <p>El <italic>clamp</italic> euglic&#233;mico hiperinsulin&#233;mico es un ejemplo de t&#233;cnica directa que permite la determinaci&#243;n de la cantidad de insulina metabolizada por los tejidos perif&#233;ricos durante la estimulaci&#243;n con insulina. Aunque actualmente sea la t&#233;cnica est&#225;ndar-oro para evaluaci&#243;n de la RI <italic>in vivo</italic>, es dispendiosa, demorada y de alta complejidad, siendo inviable su aplicaci&#243;n en estudios poblacionales, y principalmente en la pr&#225;ctica cl&#237;nica<sup>11</sup>.</p>
      <p>El &#237;ndice HOMA (<italic>Homeostasis Model Assessment</italic>) representa una de las alternativas a la t&#233;cnica de <italic>clamp </italic>para evaluaci&#243;n de la RI. Es <italic>un</italic> modelo matem&#225;tico que predice el nivel de RI a partir de la glucemia e insulinemia basales en las condiciones de homeostasis, siendo representado por la ecuaci&#243;n<sup>12</sup>:</p>
      <p>HOMA = [Insulinemia de ayuno (mU/l) x Glicemia de ayuno (mmol/l)] / 22,5</p>
      <p>El HOMA viene siendo ampliamente utilizado, principalmente en estudios poblacionales, debido a la facilidad de su aplicaci&#243;n y a la correlaci&#243;n fuerte y significante con las t&#233;cnicas directas de evaluaci&#243;n de la RI observadas en los trabajos de evaluaci&#243;n<sup>13,14</sup>. Con todo, para diagn&#243;stico o acompa&#241;amiento individual, su utilizaci&#243;n todav&#237;a requiere cautela en las cuestiones relacionadas al muestreo sangu&#237;neo y a la deficiente estandarizaci&#243;n de ensayos a ser utilizados por los laboratorios en el dosaje de insulina<sup>4</sup>, se&#241;alando la necesidad de m&#233;todos m&#225;s accesibles y viables para la pr&#225;ctica cl&#237;nica.</p>
      <p>
        <bold>Indicadores antropom&#233;tricos</bold>
      </p>
      <p>El desarrollo de la tomograf&#237;a computarizada y de la imagen de resonancia magn&#233;tica represent&#243; un avance importante en la investigaci&#243;n de composici&#243;n corporal en seres humanos, pues permiten la medici&#243;n esmerada y precisa de las grasas visceral y subcut&#225;nea localizadas en la regi&#243;n abdominal. La ultrasonograf&#237;a y la DEXA (<italic>dual energy x-ray absorptiometry</italic>) tambi&#233;n pueden ser utilizadas en la evaluaci&#243;n de la grasa abdominal, aunque esta &#250;ltima no haga la distinci&#243;n entre grasa subcut&#225;nea y visceral<sup>15,16</sup>. Sin embargo, estas t&#233;cnicas son dispendiosas y muchas veces no est&#225;n disponibles.</p>
      <p>Las medidas antropom&#233;tricas son indicadores del estado nutricional, presentan bajo costo, inocuidad, simplicidad en su ejecuci&#243;n y han servido como indicadores de la obesidad<sup>17</sup>. Las correlaciones entre indicadores antropom&#233;tricos y RI han sido ampliamente estudiadas, destac&#225;ndolos como indicadores no invasivos para la evaluaci&#243;n del riesgo de RI, tanto en la investigaci&#243;n epidemiol&#243;gica como en la pr&#225;ctica cl&#237;nica.</p>
      <p>Los &#237;ndices antropom&#233;tricos pueden ser clasificados seg&#250;n el tipo de obesidad evaluada<sup>17</sup>. Entre los indicadores de obesidad central est&#225;n el per&#237;metro de la cintura (PC), el di&#225;metro abdominal sagital (DAS), el &#237;ndice de conicidad (ICO) y la relaci&#243;n cintura/estatura (RCE). La distribuci&#243;n de la grasa corporal ha sido evaluada por la relaci&#243;n cintura/cadera (RCC), por el &#237;ndice sagital (IS), por la relaci&#243;n cintura/muslo (RCintM) y por la relaci&#243;n cuello/muslo (RCueM). Para la obesidad generalizada, el &#237;ndice de masa corporal (IMC) ha sido el m&#225;s utilizado. La <xref ref-type="table" rid="es_a25tab01-body3">Tabla 1</xref> detalla los principales estudios discutidos en esta revisi&#243;n que evaluaron los indicadores antropom&#233;tricos como predictores de RI.</p>
      <p content-type="asset">
        <table-wrap id="es_a25tab01-body3">
          <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gt01-es.jpg"/></table-wrap>
      </p>
      <p>Aunque los indicadores de obesidad est&#233;n relacionados a la RI, vale alertar que la RI no es una alteraci&#243;n metab&#243;lica exclusiva de individuos portadores de obesidad y de diabetes <italic>mellitus</italic> tipo 2, como sucede en los pacientes portadores de diabetes lipoatr&#243;fico, en que hay defecto gen&#233;tico de la acci&#243;n de la insulina en individuos magros. De la misma forma, algunos pacientes con IMC normal pueden presentar RI en virtud de la acumulaci&#243;n de grasa visceral, constituyendo el fenotipo conocido como MONW <italic>- Metabolically Obese Normal Weight</italic><sup>18</sup>.</p>
      <p>
        <bold>Per&#237;metro de la cintura</bold>
      </p>
      <p>La practicidad de aplicaci&#243;n del per&#237;metro de la cintura (PC), su asociaci&#243;n con factores de riesgo cardiovascular y la correlaci&#243;n fuerte con el &#225;rea de grasa visceral medida por tomograf&#237;a computarizada, del orden de 0,73 a 0,81<sup>19,20</sup>,son caracter&#237;sticas que lo volvieron el indicador de adiposidad abdominal m&#225;s utilizado. Adem&#225;s, la evaluaci&#243;n del PC est&#225; en las propuestas del <italic>European Group for the Study of Insulin Resistance</italic><sup>21</sup>, de la <italic>International Diabetes Federation</italic><sup>22</sup> y del<italic> National Cholesterol Education Program</italic> - NCEP-ATP III<sup>23 </sup>para el diagn&#243;stico del s&#237;ndrome de RI.</p>
      <p>En 1995, Han et al<sup>24</sup> demostraron que valores de PC encima de 80 y 88 cm para las mujeres y encima de 94 cm y de 102 cm para los hombres indicaban riesgo aumentado y muy aumentado, respectivamente, de complicaciones metab&#243;licas. Posteriormente, el NCEP-ATP III<sup>23</sup> adopt&#243; los valores de 88 y 102 cm para el diagn&#243;stico de obesidad central en mujeres y hombres, respectivamente, los cuales han sido utilizados inclusive en el Brasil. Las poblaciones difieren entre s&#237; de acuerdo con el nivel de riesgo presentado para un dado PC, siendo imposible la determinaci&#243;n de puntos de corte globalmente aplicables. La <italic>International Diabetes Federation</italic> recomienda la utilizaci&#243;n de diferentes puntos de corte seg&#250;n la etnia (<xref ref-type="table" rid="tab02-body3">Tabla 2</xref>)<sup>22</sup>.</p>
      <table-wrap id="tab02-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gt02-es.jpg"/></table-wrap>
      <p>Aunque el PC sea largamente difundido, hay descripciones diferentes para la medici&#243;n y, consecuentemente, ausencia de consenso entre los investigadores y protocolos publicados, lo que puede generar conflictos en el momento de la toma de la medida. Entre las m&#225;s utilizadas est&#225;n el punto medio entre la cresta il&#237;aca y la &#250;ltima costilla, recomendado por la Organizaci&#243;n Mundial de la Salud<sup>25</sup>; la menor cintura entre el t&#243;rax y la cadera, recomendada por el <italic>Anthropometric Standardization Reference Manual</italic><sup>26</sup>; el nivel inmediatamente encima de las crestas il&#237;acas, recomendado por el <italic>National Institute of Health</italic><sup>27</sup>; y el nivel umbilical<sup>8</sup> (<xref ref-type="fig" rid="es_a25fig01-body3">Figura 1</xref>).</p>
      <p content-type="asset">
        <fig id="es_a25fig01-body3">
          <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf01-es.jpg"/></fig>
      </p>
      <p>Ross et al<sup>28</sup> verificaron que el protocolo utilizado para la medici&#243;n del PC no posee influencia sustancial en su asociaci&#243;n con las enfermedades cardiovasculares y la diabetes tipo 2. En el estudio de Wang et al<sup>29</sup>, aunque no hayan sido realizadas correlaciones entre PC y riesgo de morbilidades, los autores sugieren que las comparaciones entre diferentes trabajos solamente son v&#225;lidas cuando el mismo lugar anat&#243;mico es utilizado para la medici&#243;n. Esos investigadores realizaron comparaciones entre las medidas de PC tomadas en cuatro lugares (menor cintura; inmediatamente abajo de la &#250;ltima costilla; punto medio entre la cresta il&#237;aca y la &#250;ltima costilla e inmediatamente encima de la cresta il&#237;aca) en 111 individuos. En ambos sexos, fueron encontradas diferencias, mostrando que los cuatro lugares no son id&#233;nticos.</p>
      <p>Diversos estudios han evaluado la relaci&#243;n entre el PC y la RI. En un trabajo realizado con 8.400 individuos, el PC se asoci&#243; de forma positiva e independiente a la diabetes tipo 2<sup>30</sup>. En el trabajo de Weidner et al<sup>31</sup>, el PC fue la primera variable antropom&#233;trica en el an&#225;lisis de regresi&#243;n multivariada, contribuyendo con aproximadamente 37% para una variaci&#243;n en la sensibilidad a la insulina. En un estudio caso-control realizado con 300 indios (India), el PC fue identificado como el predictor m&#225;s preciso de riesgo para diabetes tipo 2 y sus indicadores bioqu&#237;micos<sup>32</sup>.</p>
      <p>En un trabajo conducido con cauc&#225;sicos, el PC fue identificado como fuerte predictor de RI, especialmente en los hombres. Fueron evaluados los mejores puntos de corte de PC para la predicci&#243;n de la RI, siendo 97,5 cm y 106,5 cm los valores encontrados para las mujeres y hombres, respectivamente. Con todo, cuando son comparados a los valores de 88 cm para las mujeres y de 102 cm para los hombres, recomendados por el NCEP-ATP III<sup>23</sup>, los nuevos puntos de corte no se mostraron superiores en identificar individuos con RI<sup>33</sup>.</p>
      <p>En el estudio de Pouliot et al<sup>19</sup>, el incremento en las medidas de PC fue consistente al aumento en la glucemia e insulinemia de ayuno y post-prandial, especialmente en las mujeres, sugiriendo que esas medidas son indicadores de riesgo cardiovascular. Los autores sugieren que valores de PC encima de 100 cm est&#225;n relacionados a una mayor posibilidad de desarrollo de complicaciones metab&#243;licas.</p>
      <p>
        <bold>Di&#225;metro abdominal sagital</bold>
      </p>
      <p>El di&#225;metro abdominal sagital (DAS) representa la altura abdominal, comprendiendo la distancia entre la espalda y el abdomen<sup>34</sup>. Puede ser medido con el individuo de pie<sup>35</sup> o en la posici&#243;n supina (<xref ref-type="fig" rid="es_a25fig02-body3">Figura 2</xref>), siendo esta &#250;ltima la posici&#243;n m&#225;s utilizada<sup>7,35,36</sup>.</p>
      <p content-type="asset">
        <fig id="es_a25fig02-body3">
          <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf02-es.jpg"/></fig>
      </p>
      <p>En la posici&#243;n supina, el tejido adiposo visceral tiende a elevar la pared abdominal en la direcci&#243;n sagital, y el tejido adiposo abdominal subcut&#225;neo anterior o lateral comprime el abdomen, o tiende a descender hacia los lados debido a la fuerza de la gravedad. As&#237;, se espera que el DAS medido en la posici&#243;n supina refleje principalmente el volumen de tejido adiposo visceral<sup>37</sup>.</p>
      <p>El lugar anat&#243;mico utilizado para la medici&#243;n diverge entre los estudios, siendo utilizada la menor cintura entre el t&#243;rax y la cadera<sup>38</sup>; la mayor altura abdominal<sup>39</sup>; la cicatriz umbilical<sup>40</sup> el punto medio entre la &#250;ltima costilla y la cresta il&#237;aca<sup>36</sup>; y el punto medio entre las crestas il&#237;acas<sup>41</sup>. Este &#250;ltimo coincide con la ubicaci&#243;n de las v&#233;rtebras lumbares L4 e L5, el lugar m&#225;s utilizado por las t&#233;cnicas de imagen para cuantificaci&#243;n del &#225;rea de tejido adiposo visceral y, tal vez, el m&#225;s indicado para la medici&#243;n del DAS<sup>42</sup>.</p>
      <p>La medici&#243;n del DAS puede ser realizada por antropometr&#237;a con el auxilio de un <italic>caliper</italic> abdominal, o por t&#233;cnicas de imagen, como la tomograf&#237;a computarizada o la imagen de resonancia magn&#233;tica, pues varios estudios demostraron fuerte correlaci&#243;n entre ambas t&#233;cnicas<sup>36,43</sup>.</p>
      <p>El DAS ha sido recomendado como indicador de deposici&#243;n de grasa abdominal visceral y de evaluaci&#243;n del riesgo cardiovascular<sup>44,45</sup>. Recientemente, fueron propuestos puntos de corte para la evaluaci&#243;n del DAS en brasile&#241;os basados en una cantidad de grasa abdominal visceral elevada, correspondiente a valor superior a 100 cm<sup>2</sup>. Para el sexo femenino y masculino, los puntos de corte fueron 19,3 y 20,5 cm, respectivamente<sup>20</sup>.</p>
      <p>El DAS ha mostrado fuerte asociaci&#243;n con la intolerancia a la glucosa y a la RI. Gustat et al<sup>38</sup> identificaron el DAS como predictor independiente de glucemia e insulinemia, se&#241;alando esa medida antropom&#233;trica como excelente marcador de RI.</p>
      <p>En el estudio de Ris&#233;rus et al<sup>7</sup>, el DAS present&#243; correlaci&#243;n m&#225;s fuerte con RI, glucemia, insulinemia, p&#233;ptidos C e hiperproinsulinemia que el IMC, el PC y la RCC. En el an&#225;lisis de regresi&#243;n m&#250;ltiple univariada, incluyendo todas las variables antropom&#233;tricas, el DAS fue el &#250;nico predictor independiente de RI. En el estudio de Petersson et al<sup>44</sup>, conducido con mujeres suecas, el DAS tambi&#233;n fue el mejor marcador cl&#237;nico de RI entre los dem&#225;s, incluyendo el PC, la RCC y el IMC. En el estudio de Pouliot et al<sup>19</sup>, adem&#225;s del PC, el incremento en el DAS tambi&#233;n fue consistente al aumento en la glucemia e insulinemia de ayuno y post-prandial. En ese trabajo, valores de DAS encima de 25 cm estaban asociados a la mayor probabilidad de desarrollo de disturbios metab&#243;licos con potencial aterog&#233;nico.</p>
      <p>
        <bold>Relaci&#243;n cintura/cadera</bold>
      </p>
      <p>La relaci&#243;n cintura/cadera (RCC) es el &#237;ndice de distribuci&#243;n regional de la grasa corporal m&#225;s utilizado en la investigaci&#243;n epidemiol&#243;gica. Se basa en la raz&#243;n entre los valores de PC y el per&#237;metro de la cadera (PCad). El lugar anat&#243;mico m&#225;s utilizado para la medici&#243;n del PCad es a la altura del gran trocanter, recomendado por la OMS<sup>25</sup>. El PC y el PCad reflejan diferentes aspectos de la composici&#243;n corporal y poseen efectos independientes y opuestos en la determinaci&#243;n del riesgo de enfermedades cardiovasculares y sus factores de riesgo. Cinturas estrechas y caderas anchas est&#225;n asociadas a la protecci&#243;n contra enfermedades cardiovasculares. Esa relaci&#243;n ha sido explicada por la siguiente teor&#237;a: cadera estrecha refleja una cantidad reducida de masa muscular, lo que contribuye a la menor actividad de la insulina en la musculatura esquel&#233;tica y para menor concentraci&#243;n y actividad de la lipasa lipoproteica en los m&#250;sculos, con concomitante reducci&#243;n en la captaci&#243;n y utilizaci&#243;n de los &#225;cidos grasos por las c&#233;lulas musculares. En contrapartida, cadera ancha presenta mayor concentraci&#243;n de la lipasa lipoproteica debido a la mayor cantidad de tejido muscular. Adem&#225;s, hay menor <italic>turnover</italic> de &#225;cidos grasos en el tejido adiposo gl&#250;teofemoral en relaci&#243;n al tejido adiposo visceral, lo que favorece la sensibilidad insul&#237;nica. Con todo, los efectos independientes de cada uno de los per&#237;metros pueden ser confundidos en la RCC, siendo la interpretaci&#243;n de sus valores bastante m&#225;s compleja<sup>46</sup>.</p>
      <p>La RCC es parcialmente independiente de la adiposidad total. Individuos magros y obesos pueden presentar el mismo valor de RCC, a&#250;n habiendo variaci&#243;n interindividual substancial en la masa grasa total y en las &#225;reas de tejido adiposo abdominal visceral y subcut&#225;neo<sup>19</sup>. Adem&#225;s, la RCC puede mantenerse inalterada a&#250;n cuando ocurran modificaciones en la adiposidad corporal debido a alteraciones semejantes en ambos per&#237;metros, que no alteran la relaci&#243;n final. De esa forma, es importante tener cautela al utilizar la RCC como indicador de la acumulaci&#243;n de grasa visceral, siendo esa relaci&#243;n inapropiada para evaluar cambios en la cantidad de grasa visceral durante la p&#233;rdida o incremento de peso<sup>47</sup>.</p>
      <p>En el estudio de Pouliot et al<sup>19</sup>, aunque la RCC no haya sido la mejor predictora de disturbios en el metabolismo de la glucosa y de la insulina, los autores sugirieron que valores de RCC encima de 0,8 para las mujeres y de 1,0 para los hombres estar&#237;an asociados a esas alteraciones metab&#243;licas. </p>
      <p>En los trabalhos de Riserus et al<sup>7</sup>, Mamtani et al<sup>32</sup> y Petterson et al<sup>44</sup>, la RCC se present&#243; como un instrumento menos &#250;til para predecir la RI, comparada a las dem&#225;s medidas antropom&#233;tricas estudiadas. </p>
      <p>
        <bold>&#205;ndice sagital</bold>
      </p>
      <p>Aunque menos conocido y utilizado entre los investigadores y los profesionales de la salud, el &#237;ndice sagital (IS) fue propuesto como una alternativa a la RCC para la estimativa de la distribuci&#243;n de grasa corporal y para la predicci&#243;n de morbilidades. El IS es representado por la raz&#243;n entre el DAS (cm) y el per&#237;metro medio del muslo (cm). Para usarlo, se parti&#243; del principio de que el DAS y el per&#237;metro medio de la muslo, medido en el punto medio entre el pliegue inguinal y el borde proximal de la r&#243;tula (<xref ref-type="fig" rid="fig03-body3">Figura 3</xref>), ser&#237;an medidas con mejor representatividad de los tejidos de inter&#233;s, comparadas al PC y al Pcad, respectivamente<sup>47</sup>. </p>
      <fig id="fig03-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf03-es.jpg"/></fig>
      <p>La medida del per&#237;metro medio del muslo comprende la musculatura esquel&#233;tica, el f&#233;mur y el tejido adiposo subcut&#225;neo e intramuscular. Esos tres tejidos son an&#225;logos a los que circundan el contenido intraabdominal, compuesto por la musculatura esquel&#233;tica, por las v&#233;rtebras y por el tejido adiposo subcut&#225;neo. Como el tejido adiposo visceral es el compartimiento abdominal de inter&#233;s, el per&#237;metro medio del muslo representa una medida de comparaci&#243;n con las medidas abdominales<sup>47</sup>. Como ventaja, al contrario del PCad, el per&#237;metro medio del muslo no es afectado por variaciones en la arquitectura p&#233;lvica. Adem&#225;s, el per&#237;metro medio del muslo y el DAS son medidas con elevada precisi&#243;n<sup>34</sup>. El punto medio del muslo es el m&#225;s utilizado por representar la porci&#243;n central del m&#250;sculo, que refleja la masa muscular y la pr&#225;ctica de ejercicio f&#237;sico. Individuos con elevado contenido de masa muscular y tejido adiposo subcut&#225;neo en el muslo pueden presentar mayor respuesta a la se&#241;alizaci&#243;n de la insulina y menor riesgo cardiovascular<sup>47</sup>.</p>
      <p>En estudio realizado en Brasil, el IS present&#243; menor correlaci&#243;n con el tejido adiposo visceral que el DAS, mientras tanto no hubo correlaci&#243;n del IS con el &#225;rea de grasa abdominal subcut&#225;nea<sup>20</sup>. En el estudio de Kahn et al<sup>48</sup>, entre las medidas antropom&#233;tricas tradicionales, como el IMC y la RCQ, el IS fue el mejor predictor de muerte coronaria s&#250;bita en hombres. Smith et al<sup>49</sup> evaluaron la fuerza de la asociaci&#243;n de seis par&#225;metros antropom&#233;tricos con conocidos factores de riesgo cardiovascular en hombres de diferentes etnias. El IS fue el que present&#243; mayor <italic>odds ratio</italic> para el riesgo de enfermedad cardiovascular. Aunque esos trabajos hayan presentado buenos resultados para el IS, estudios evaluando su utilidad en predecir la RI y dem&#225;s factores de riesgo cardiovascular todav&#237;a son escasos. </p>
      <p>
        <bold>Relaci&#243;n cintura/muslo</bold>
      </p>
      <p>La relaci&#243;n cintura/muslo (RCintM) presenta fundamentaci&#243;n semejante a la aplicada al IS en lo que dice respeto a las ventajas de la utilizaci&#243;n del per&#237;metro del muslo en detrimento del PCad, siendo calculada a partir de la raz&#243;n entre los valores de PC (cm) y el per&#237;metro medio del muslo (cm).</p>
      <p>En el estudio de Chuang et al<sup>8</sup>, con orientales (n = 6.007), entre las 32 medidas evaluadas por medio de un <italic>scanning</italic> a laser en tres dimensiones, el PC, representando el tronco, y el per&#237;metro medio del muslo, representando la parte inferior del cuerpo, fueron los mejores indicadores de diabetes tipo 2. Al comparar la RCintM con indicadores antropom&#233;tricos conocidos, entre ellos el IMC, la RCC y el PC, los autores identificaron correlaciones m&#225;s fuertes para la RCintM. En el estudio de Kahn et al<sup>48</sup>, la RCintM present&#243; buen desempe&#241;o para la evaluaci&#243;n del riesgo de enfermedad cardiovascular, paralelamente al IS.</p>
      <p>
        <bold>Relaci&#243;n cuello/muslo</bold>
      </p>
      <p>La relaci&#243;n cuello/muslo (RCueM) comprende la raz&#243;n entre el per&#237;metro del cuello (cm), medido en el punto medio de la altura del cuello (<xref ref-type="fig" rid="fig04-body3">Figura 4</xref>), y el per&#237;metro medio del muslo (cm), los cuales han sido usados como &#237;ndices de distribuci&#243;n del tejido adiposo subcut&#225;neo de las regiones corporales superior e inferior, respectivamente. Siguiendo el modelo de composici&#243;n corporal tricopartimental (tejido adiposo subcut&#225;neo y visceral y masa magra), despu&#233;s de ajuste para masa magra y para tejido adiposo visceral, Sj&#246;str&#246;m et al identificaron correlaci&#243;n positiva entre el per&#237;metro del cuello y factores de riesgo cardiovascular relacionados a la RI, mientras que el per&#237;metro del muslo present&#243; correlaci&#243;n inversa<sup>50</sup>.</p>
      <fig id="fig04-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-gf04-es.jpg"/></fig>
      <p>Laakso et al<sup>51</sup>, en estudio realizado con 541 adultos distribuidos seg&#250;n quintiles del per&#237;metro del cuello, identificaron mayores frecuencias de hiperglucemia e hiperinsulinemia en los quintiles superiores de la medida, sugiriendo la utilizaci&#243;n del per&#237;metro del cuello, en <italic>screenings</italic> poblacionales, como indicador de individuos en riesgo para RI. Ben-Noun y Laor<sup>52</sup> tambi&#233;n encontraron correlaci&#243;n significante entre el per&#237;metro del cuello con diversos factores de riesgo cardiovascular relacionados a la RI.</p>
      <p>Aunque los trabajos evaluando la RCueM sean raros, se destaca que el per&#237;metro de cuello representa una medida r&#225;pida y f&#225;cil de ser realizada, adem&#225;s de no presentar variaciones en su magnitud a lo largo del d&#237;a.</p>
      <p>
        <bold>Relaci&#243;n cintura/estatura</bold>
      </p>
      <p>La relaci&#243;n cintura/estatura (RCE) comprende la raz&#243;n entre el PC (cm) y la estatura (cm). Se basa en el presupuesto de que, para determinada estatura, hay un grado aceptable de grasa almacenada en la porci&#243;n superior del cuerpo. Aunque el efecto preciso de la estatura sobre la medida del PC sea cuantitativamente desconocido, algunos autores afirman que a estatura ejerce influencia en la magnitud del PC a lo largo del crecimiento y tambi&#233;n en la vida adulta<sup>53,54</sup>.</p>
      <p>Trabajos se&#241;alan que, adem&#225;s de que la RCE presente buena correlaci&#243;n con la grasa visceral, deber&#237;a ser el indicador antropom&#233;trico utilizado para la predicci&#243;n de riesgos metab&#243;licos asociados a la obesidad<sup>17,54</sup>. El argumento m&#225;s utilizado es que el PC<sup>54</sup> y el IMC<sup>55</sup> necesitan diversos puntos de corte dependiendo de la etnia y/o del g&#233;nero<sup>22,25</sup>, lo que supuestamente dificultar&#237;a su utilizaci&#243;n. Seg&#250;n esos autores, la manutenci&#243;n del valor del PC abajo del valor correspondiente a la mitad de la estatura representar&#237;a un mensaje simple y efectivo para toda la poblaci&#243;n, de modo de auxiliar en la prevenci&#243;n del s&#237;ndrome de RI<sup>54,55</sup>. En un estudio realizado con hombres iran&#237;es, la RCE present&#243; mejor desempe&#241;o para predecir la diabetes tipo 2 comparada al IMC<sup>9</sup>.</p>
      <p>Entre las ventajas de la RCE estar&#237;a su relaci&#243;n con los factores de riesgo cardiovascular, incluyendo la insulinemia de ayuno<sup>17</sup>; la elevada sensibilidad para detectar factores de riesgo precozmente, cuando es comparada al IMC; y la simplicidad de ejecuci&#243;n aliada a la facilidad de un &#250;nico punto de corte para clasificaci&#243;n de los individuos, en que el valor de 0,5, determinado con base en el balance &#243;ptimo entre sensibilidad y especificidad, podr&#237;a ser utilizado universalmente<sup>55,56</sup>. El estudio de Ho et al<sup>17</sup> encontr&#243; el valor de 0,48 como mejor punto de corte para predecir hiperinsulinemia en hombres chinos.</p>
      <p>A pesar de que la RCE utiliza la estatura y permite su aplicaci&#243;n en diversas etnias, se puede cuestionar si el distinto est&#225;ndar de distribuci&#243;n de grasa corporal entre hombres y mujeres dificultar&#237;a la utilizaci&#243;n de un &#250;nico punto de corte para ambos sexos. Sin embargo, los hombres son m&#225;s altos y presentan mayores medidas de PC en relaci&#243;n a las mujeres. De esa forma, las medias de RCE son semejantes para ambos sexos debido al ajuste para la estatura<sup>54</sup>.</p>
      <p>
        <bold>&#205;ndice de conicidad</bold>
      </p>
      <p>Propuesto por Valdez<sup>57</sup>, el &#237;ndice de conicidad (ICO) representa un indicador de obesidad abdominal. Considera que individuos con menor acumulaci&#243;n de grasa en la regi&#243;n central tendr&#237;an la forma corporal semejante a la de un cilindro, mientras que aquellos con mayor acumulaci&#243;n se asemejar&#237;an a un doble cono, teniendo este una base en com&#250;n.</p>
      <p>La ecuaci&#243;n del ICO toma en consideraci&#243;n las medidas de PC, peso corporal, estatura y la constante de 0,109, que representa la conversi&#243;n de las unidades de volumen y masa a unidades de longitud<sup>58</sup>:</p>
      <p>&#205;ndice de conicidad <graphic xlink:href="1678-4170-abc-95-01-0e14-00025-e01-es.jpg"/></p>
      <p>El ICO es de interpretaci&#243;n simple, ya que el denominador corresponde al cilindro producido por el peso y por la estatura del evaluado. De esa forma, un ICO igual a 1,20 significa que el PC es 1,20 vez mayor que el per&#237;metro del cilindro generado a partir del peso y de la estatura de aquea persona, reflejando el exceso de adiposidad en la regi&#243;n abdominal. El ICO no presenta unidad de medida y su franja te&#243;rica es de 1,00 (cilindro perfecto) a 1,73 (cono doble)<sup>58</sup>.</p>
      <p>Entre sus ventajas, est&#225; el hecho de incluir en su estructura un ajuste del PC para peso y estatura, permitiendo comparaciones directas de adiposidad abdominal entre los individuos o entre las poblaciones. Adem&#225;s, el ICO presenta d&#233;bil correlaci&#243;n con la estatura, lo que es deseable para cualquier indicador de obesidad<sup>57,58</sup>.</p>
      <p>En un estudio multic&#233;ntrico, reuniendo 2.240 adultos, la insulinemia present&#243; est&#225;ndares de correlaci&#243;n consistentes con el ICO<sup>58</sup>. Pitanga y Lessa<sup>6</sup> condujeron un trabajo en Brasil con 2.297 individuos e identificaron el ICO como discriminador de glucemia y de riesgo cardiovascular. Esos autores desarrollaron una tabla para facilitar la utilizaci&#243;n del ICO, en la cual, a partir de los valores de peso y estatura se tiene el denominador del &#237;ndice ya calculado. De esa forma, la conicidad de cualquier valor de cintura, para un peso dado y una dada estatura, puede ser r&#225;pidamente analizada, posibilitando pronosticar los riesgos de enfermedades asociadas a la adiposidad abdominal, como la RI.</p>
      <p>En contrapartida, en el estudio de Mantzoros et al<sup>59</sup>, realizado en Grecia, con 280 mujeres sanas de 18 a 24 a&#241;os, el ICO present&#243; correlaci&#243;n muy d&#233;bil (r = 0,13, p = 0,03) con la insulinemia de ayuno. Mamtani y Kuljarni<sup>32</sup>, comparando el desempe&#241;o de diversos par&#225;metros antropom&#233;tricos relacionados a la obesidad central, verificaron que el ICO fue el par&#225;metro que present&#243; menor precisi&#243;n predictiva para las medidas de obesidad central. En ese mismo estudio, el ICO no present&#243; correlaci&#243;n con las glucemias de ayuno y post-prandial. As&#237;, se observa la necesidad de m&#225;s investigaciones acerca de ese &#237;ndice para determinar su viabilidad en la predicci&#243;n del riesgo de RI.</p>
      <p>
        <bold>&#205;ndice de masa corporal</bold>
      </p>
      <p>El &#237;ndice de masa corporal (IMC) es calculado a partir de la raz&#243;n entre el peso corporal (kg) y la estatura (m) elevada al cuadrado<sup>60</sup>. Representa el indicador del estado nutricional m&#225;s conocido y utilizado para evaluaci&#243;n de adultos y a&#241;osos , debido a su facilidad de aplicaci&#243;n y al bajo costo. Se caracteriza como un indicador de adiposidad generalizada debido a su incapacidad de evaluar la distribuci&#243;n de la grasa corporal. Modificaciones en el IMC no reflejan el lugar anat&#243;mico en el cual el individuo puede haber perdido o ganado peso<sup>61</sup>. De forma general, se observa que el IMC presenta correlaciones m&#225;s d&#233;biles con la grasa visceral que el PC y el DAS<sup>20,43</sup>.</p>
      <p>Los trabajos que evaluaron la capacidad del IMC para predecir RI vienen presentando resultados contradictorios. En el estudio de Farin et al<sup>62</sup> no hubo diferencia en la magnitud de las correlaciones entre el IMC y el PC con la RI en cauc&#225;sicos. A partir del an&#225;lisis de regresi&#243;n, ambos indicadores de adiposidad generalizada y central presentaron la misma capacidad de identificar individuos con RI. En el trabajo de Ascaso et al<sup>63</sup>, conducido con espa&#241;oles, tanto el PC como el IMC se correlacionaron con la RI. En el an&#225;lisis de regresi&#243;n log&#237;stica, apenas el IMC permaneci&#243; en el modelo con una <italic>odds ratio</italic> de 2,6, en tanto que el PC perdi&#243; significancia estad&#237;stica. Chang et al<sup>64</sup> identificaron el IMC como el determinante m&#225;s importante de RI en orientales. Sin embargo, las correlaciones entre IMC y RI fueron d&#233;biles y ese fue el &#250;nico indicador antropom&#233;trico utilizado en el estudio. Ybarra et al<sup>33</sup> afirmaron que los mejores puntos de corte de IMC para predecir la RI son valores a partir de 29,5 kg/m<sup>2</sup> para las mujeres y de 30,5 kg/m<sup>2</sup> para los hombres. Se observa que tales puntos de corte se asemejan al valor de 30 kg/m<sup>2</sup> propuesto por la Organizaci&#243;n Mundial de la Salud<sup>25 </sup>para la clasificaci&#243;n de la obesidad. Con todo, vale destacar que ese trabajo fue conducido con espa&#241;oles, no pudiendo ser generalizado a las dem&#225;s etnias. Stern et al<sup>65</sup> evaluaron 2.321 individuos de diversas etnias e identificaron como puntos de corte para predicci&#243;n de RI valores de IMC &gt; 28,7 kg/m<sup>2</sup>.</p>
      <p>Aunque los trabajos citados hayan se&#241;alado resultados positivos para el IMC en la predicci&#243;n de la RI, diversos estudios que evaluaron medidas de adiposidad central<sup>7,17,44,54,66</sup>, o de distribuci&#243;n de la grasa corporal<sup>8,17</sup>, mostraron la superioridad de estas en relaci&#243;n al IMC, probablemente debido a la asociaci&#243;n entre RI y la acumulaci&#243;n de tejido adiposo visceral, que es mejor representado por esas medidas. Adem&#225;s, debido a la incapacidad del IMC de distinguir entre masa corporal magra y grasa, su utilizaci&#243;n para la predicci&#243;n de la RI puede sobreestimar el riesgo en individuos con elevada cantidad de masa muscular, como atletas, y subestimar el riesgo en a&#241;osos, cuya masa muscular generalmente se presenta reducida y hay acumulaci&#243;n aumentada de tejido adiposo visceral<sup>17</sup>.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>La escasez de estudios comparando los diversos indicadores antropom&#233;tricos en un &#250;nico trabajo dificulta la conclusi&#243;n de cual es el mejor indicador para la predicci&#243;n de RI. Con todo, el PC y el DAS parecen presentar mejor capacidad predictiva para la RI, ya que los resultados fueron m&#225;s consistentes entre los trabajos. La RCintM, el ICO, el IS, la RCueM y la RCE han demostrado resultados positivos, con todo m&#225;s estudios son necesarios para consolidarlos como indicadores de RI. Los resultados del IMC y de la RCC fueron m&#225;s inconsistentes. Aunque sea extremamente &#250;til, del punto de vista cl&#237;nico, identificar los indicadores antropom&#233;tricos de adiposidad que presentan la mejor capacidad de identificar individuos con RI, es importante considerar que, a partir de ellas, siempre ser&#225; evaluado el riesgo, pues son m&#233;todos alternativos y que, por s&#237; solos, no explican la RI como un todo. Variables importantes de influencia en la modulaci&#243;n de la acci&#243;n de la insulina como el estilo de vida y los factores gen&#233;ticos deben ser llevados en consideraci&#243;n.</p>
      <p>
        <bold>Agradecimientos</bold>
      </p>
      <p>Apoyo FAPEMIG y CNPq.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiamiento</bold>
      </p>
      <p>El presente estudio fue financiado por el CNPq y FAPEMIG.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo es parte de disertaci&#243;n de Maestrado de Ana Carolina Junqueira Vasques por la Universidad Federal de Vi&#231;osa.</p>
      <p>
        <bold>Referencias</bold>
      </p>
      <p>1. Silva EA, Flexa F, Zanella MT. Obesidade abdominal, resist&#234;ncia &#224; insulina e hipertens&#227;o: impacto sobre a massa e a fun&#231;&#227;o do ventr&#237;culo esquerdo em mulheres. Arq Bras Cardiol. 2007; 89 (2): 86-92.</p>
      <p>2. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke. 2008; 39 (1): 30-5.</p>
      <p>3. Ribeiro Filho FF, Mariosa LS, Ferreira SR, Zanella MT. Gordura visceral e s&#237;ndrome metab&#243;lica: mais que uma simples associa&#231;&#227;o. Arq Bras Endocrinol Metab. 2006; 50 (2): 230-8.</p>
      <p>4. Vasques ACJ, Rosado LEFPL, Alfenas RCG, Geloneze B. An&#225;lise cr&#237;tica do uso dos &#237;ndices do Homeostasis Model Assessment (HOMA) na avalia&#231;&#227;o da resist&#234;ncia &#224; insulina e capacidade funcional das c&#233;lulas-b pancre&#225;ticas. Arq Bras Endocrinol Metab. 2008; 52 (1): 32-9.</p>
      <p>5. Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism. 2000; 49 (8): 1001-5.</p>
      <p>6. Pitanga FJG, Lessa I. Sensibilidade e especificidade do &#237;ndice de conicidade como discriminador do risco coronariano de adultos em Salvador, Brasil. Rev Bras Epidemiol. 2004; 7 (3): 259-69.</p>
      <p>7. Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004; 27 (8): 2041-6.</p>
      <p>8. Chuang YC, Hsu KH, Hwang CJ, Hu PM, Lin TM, Chiou WK. Waist-to-thigh ratio can also be a better indicator associated with type 2 diabetes than traditional anthropometrical measurements in Taiwan population. Ann Epidemiol. 2006; 16 (5): 321-31.</p>
      <p>9. Meshkani R, Taghikhani M, Larijani B, Khatami S, Khoshbin E, Adeli K. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta. 2006; 371 (1-2): 169-75</p>
      <p>10. Geloneze B, Tambascia MA. Avalia&#231;&#227;o laboratorial e diagn&#243;stico de resist&#234;ncia insul&#237;nica. Arq Bras Endocrinol Metab. 2006; 50 (2): 208-15.</p>
      <p>11. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237 (3): 214-23.</p>
      <p>12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28 (7): 412-9.</p>
      <p>13. Hermans MP, Pepersack TM, Godeaux LH, Beyer I, Turc AP. Prevalence and determinants of impaired glucose metabolism in frail elderly patients: the Belgian Elderly Diabetes Survey (BEDS). J Gerontol A Biol Sci Med Sci. 2005; 60 (2): 241-7.</p>
      <p>14. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23 (1): 57-63.</p>
      <p>15. Ross R. Advances in the application of imaging methods in applied and clinical physiology. Acta Diabetol. 2003; 40 (Suppl 1): 45-50.</p>
      <p>16. Leite CC, Matsuda D, Wajchenberg BL, Cerri GG, Halpern A. Correla&#231;&#227;o da medida de espessura intra-abdominal medida pela ultra-sonografia com os fatores de risco cardiovascular. Arq Bras Endocrinol Metab. 2000; 44 (1): 49-56.</p>
      <p>17. Ho SY, Lam TH, Janus ED. Waist to stature ratio is more strongly associated with cardiovascular risk factors than other simple anthropometric indices. Ann Epidemiol. 2003; 13 (10): 683-91.</p>
      <p>18. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab. 2004; 89 (10): 5013-20.</p>
      <p>19. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994; 73 (7): 460-8.</p>
      <p>20. Sampaio LR, Simoes EJ, Assis AM, Ramos LR. Validade e confiabilidade do di&#226;metro abdominal sagital enquanto preditor de gordura abdominal visceral. Arq Bras Endocrinol Metab. 2007; 51 (6): 980-6.</p>
      <p>21. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16 (5): 442-3.</p>
      <p>22. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23 (5): 469-80.</p>
      <p>23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285 (19): 2486-97.</p>
      <p>24. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995; 311: 1401-5.</p>
      <p>25. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: WHO Technical Report Series 894. World Health Organization, 2000. </p>
      <p>26. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: Human Kinetics Pub; 1988.</p>
      <p>27. National Institute of Health (NIH). The practical guide identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: NIH; 2000.</p>
      <p>28. Ross R, Berentzen T, Bradshaw AJ, Jansson I, Kahn HS, Katzmarzyk PT, et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev. 2007; 9 (4): 312-25.</p>
      <p>29. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003; 77 (2): 379-84.</p>
      <p>30. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord. 2004; 28 (3): 402-9.</p>
      <p>31. Weidner MD, Gavigan KE, Tyndall GL, Hickey MS, McCammon MR, Houmard JA. Which anthropometric indices of regional adiposity are related to the insulin resistance of aging? Int J Obes Relat Metab Disord. 1995; 19 (5): 325-30.</p>
      <p>32. Mamtani MR, Kulkarni HR. Predictive performance of anthropometric indexes of central obesity for the risk of type 2 diabetes. Arch Med Res. 2005; 36 (5): 581-9.</p>
      <p>33. Ybarra J, Sanchez-Hernandez J, Pou J, Fernandez S, Gich I, Ordonez-Llamos J, et al. Anthropometrical measures are easily obtainable sensitive and specific predictors of insulin resistance in healthy individuals. Prevention and Control. 2005; 1 (2): 175-81.</p>
      <p>34. Williamson DF, Kahn HS, Worthman CM, Burnette JC, Russell CM. Precision of recumbent anthropometry. Am J Hum Biol. 1993; 5 (2): 159-67.</p>
      <p>35. Iribarren C, Darbinian JA, Lo JC, Fireman BH, Go AS. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006; 164 (12): 1150-9.</p>
      <p>36. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M. Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr. 1993; 70 (1): 47-58.</p>
      <p>37. Sj&#246;strom L. A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991; 15 (Suppl 2): 19-30.</p>
      <p>38. Gustat J, Elkasabany A, Srinivasan S, Berenson GS. Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study. Am J Epidemiol. 2000; 151 (9): 885-91.</p>
      <p>39. Kullberg J, von Below C, Lonn L, Lind L, Ahlstrom H, Johansson L. Practical approach for estimation of subcutaneous and visceral adipose tissue. Clin Physiol Funct Imaging. 2007; 27 (3): 148-53.</p>
      <p>40. Ohrvall M, Berglund L, Vessby B. Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes Relat Metab Disord. 2000; 24 (4): 497-501.</p>
      <p>41. Kahn HS, Simoes EJ, Koponen M, Hanzlick R. The abdominal diameter index and sudden coronary death in men. Am J Cardiol. 1996; 78 (8): 961-4.</p>
      <p>42. Kahn HS. Alternative anthropometric measures of risk: possible improvements on the waist-hip ratio. In: Medeiros-Neto G, Halpern A, Bouchard C. (eds.). Progress in obesity research. 9th ed. London: John Libbey Eurotext Ltd; 2003 .p. 639-43.</p>
      <p>43. Despres JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr. 1991; 54 (3): 471-7.</p>
      <p>44. Petersson H, Daryani A, Riserus U. Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovasc Diabetol. 2007; 6: 10.</p>
      <p>45. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr. 2001; 74 (3): 315-21.</p>
      <p>46. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ. Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr. 1993; 57 (3): 327-33.</p>
      <p>47. Kahn HS. Choosing an index for abdominal obesity: an opportunity for epidemiologic clarification. J Clin Epidemiol. 1993; 46: 491-4.</p>
      <p>48. Kahn HS, Austin H, Williamson DF, Arensberg D. Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol. 1996; 49 (9): 1017-24.</p>
      <p>49. Smith DA, Ness EM, Herbert R, Schechter CB, Phillips RA, Diamond JA, et al. Abdominal diameter index: a more powerful anthropometric measure for prevalent coronary heart disease risk in adult males. Diabetes Obes Metab. 2005; 7 (4): 370-80.</p>
      <p>50. Sj&#246;str&#246;m CD, H&#229;kang&#229;rd AC, Lissner L, Sj&#246;str&#246;m L. Body compartment and subcutaneous adipose tissue distribution- risk factor patterns in obese subjects. Obes Res. 1995; 3: 9-22.</p>
      <p>51. Laakso M, Matilainen V, Kein&#228;nen-Kiukaanniemi S. Association of neck circumference with insulin resistance-related factors. Int J Obes Relat Metab Disord. 2002; 26 (6): 873-5.</p>
      <p>52. Ben-Noun L, Laor A. Relationship of neck circumference to cardiovascular risk factors. Obes Res. 2003; 11 (2): 226-31.</p>
      <p>53. McCarthy HD, Ashwell M. A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message--'keep your waist circumference to less than half your height'. Int J Obes. 2006; 30 (6): 988-92.</p>
      <p>54. Parikh RM, Joshi SR, Menon PS, Shah NS. Index of central obesity: a novel parameter. Med Hypotheses. 2007; 68 (6): 1272-5.</p>
      <p>55. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005; 56 (5): 303-7.</p>
      <p>56. Hsieh SD, Muto T. The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women. Prev Med. 2005; 40 (2): 216-20.</p>
      <p>57. Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991; 44 (9): 955-6.</p>
      <p>58. Valdez R, Seidell JC, Ahn YI, Weiss KM. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease: a cross-population study. Int J Obes Relat Metab Disord. 1993; 17 (2): 77-82.</p>
      <p>59. Mantzoros CS, Evagelopoulou K, Georgiadis EI, Katsilambros N. Conicity index as a predictor of blood pressure levels, insulin and triglyceride concentrations of healthy premenopausal women. Horm Metab Res. 1996; 28 (1): 32-4.</p>
      <p>60. Monteiro JC. Obesidade: diagn&#243;stico, m&#233;todos e fundamentos. In: Halpern A, Matos AFG, Suplicy HL, Mancini MC, Zanella MT. Obesidade. S&#227;o Paulo: Lemos; 1998. p. 31.</p>
      <p>61. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol. 2006; 35 (1): 83-92.</p>
      <p>62. Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr. 2006; 83 (1): 47-51.</p>
      <p>63. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin. 2001; 117 (14): 530-3.</p>
      <p>64. Chang SA, Kim HS, Yoon KH, Ko SH, Kwon HS, Kim SR, et al. Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism. 2004; 53 (2): 142-6.</p>
      <p>65. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005; 54 (2): 333-9.</p>
      <p>66. Tarastchuk JCE, Guerios EE, Bueno RRL, Andrade Pm, Nercolini PC, Ferraz JG, et al. Obesidade e interven&#231;&#227;o coronariana: devemos continuar valorizando o &#205;ndice de Massa Corp&#243;rea? Arq Bras Cardiol. 2008; 90 (5): 311-6.</p>
      <p>
        <fn id="add1-body3" fn-type="corresp">
          <label>
            <bold>Correspondencia:</bold>
          </label>
          <p> Ana Carolina Junqueira Vasques</p>
          <p> Laborat&#243;rio LIMED - Gastrocentro - UNICAMP</p>
          <p> Rua Carlos Chagas, 420</p>
          <p> 13081-970 - Bar&#227;o Geraldo, Campinas, SP - Brasil</p>
          <p> E-mail: </p>
          <p>
            <email xlink:href="anacarolinavasques@yahoo.com.br">anacarolinavasques@yahoo.com.br</email>
          </p>
        </fn>
      </p>
      <p>Art&#237;culo recibido el 29/08/08; revisado recibido el 17/03/09; aceptado el 11/05/09.</p>
    </body>
  </sub-article>
</article>
